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ABSTRACT 
Alcoholic liver disease (ALD) is a worldwide health issue claiming 2 million lives per year. 
The pathogenesis of ALD is characterized by steatosis, alcoholic hepatitis, fibrosis, cirrhosis, and 
eventually hepatocellular carcinoma. There is no ideal treatment other than liver transplantation 
for late stage of ALD, and novel treatment targets especially for early stage of ALD are still needed. 
In recent years, increasing evidence implicates the role of adipose-liver axis in in the pathogenesis 
of ALD. Chronic alcohol consumption leads to increased lipolysis, adipose tissue atrophy, and 
proinflammatory adipokine secretion. However, the mechanisms of how adipose tissue is affected 
by alcohol and contributes to ALD are largely unknown.  
In this study, I found that chronic-plus-binge alcohol treatment, a model resulting in liver 
injury and steatosis, led to smaller adipocytes and decreased adipose tissue mass. Mechanistically, 
I found that chronic-plus-binge alcohol inhibited mammalian target of rapamycin (mTOR)/Akt 
signaling pathways and enhanced autophagy degradation in epididymal adipose tissue. Although 
the adipose-specific autophagy-related gene 5 knockout (A-Atg5 KO) mice with adipose 
autophagy deficiency did not present adipose atrophy at basal condition, they were resistant to 
alcohol-induced adipose tissue atrophy. Moreover, A-Atg5 KO mice had increased adipocytes 
with multilocular lipid droplets in subcutaneous white adipose tissue. Interestingly, A-Atg5 KO 
mice were more resistant to alcohol-induced liver injury, though they still developed alcohol-
induced liver steatosis. Alcohol metabolism and reactive oxygen species generation in liver was 
not affected in A-Atg5 KO mice. While the chronic-plus-binge alcohol increased liver mRNA 
levels of several proinflammatory genes in both wild-type and A-Atg5 KO mice, A-Atg5 KO mice 
had significantly decreased induction of Ccl2. Compared with wild-type mice, A-Atg5 KO mice 
had similar serum lipids (triglycerides, free fatty acids, free glycerol), but had higher basal levels 
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of adiponectin and fibroblast growth factor 21 (FGF21). Additionally, chronic-plus-binge alcohol 
did not induce inflammation or cell death in white adipose tissues. 
I next used cultured 3T3-L1 preadipocytes to further determine the role of autophagy in 
adipocyte differentiation and how adipogenesis is affected by alcohol. I found that there was 
increased autophagy degradation along with increased levels of mitochondria proteins during 
preadipocyte adipogenesis. Using fluorescence microscopy, I found that elongated, sharp 
mitochondria signal became diffused and enhanced in mature adipocytes. Electron microscopy 
analysis revealed that the number of elongated mitochondria with clear cristae structure largely 
disappeared while electron-dense vacuoles containing undegraded cellular components frequently 
appeared during adipogenesis. Long-term cotreatment using chloroquine, a lysosome inhibitor that 
blocks autophagy degradation, sufficiently blocked 3T3-L1 adipogenesis. Intriguingly, in 
chloroquine-treated cells typical mitochondria still decreased while the electron-dense vacuoles 
containing undegraded cellular components further increased. Moreover, long-term ethanol or 
acetaldehyde treatment did not inhibit morphological changes or lipid droplet accumulation during 
adipogenesis in 3T3-L1 cells. Interestingly, short-term ethanol but not acetaldehyde treatment 
induced autophagic flux, and long-term ethanol but not acetaldehyde treatment increased 
mitochondria protein levels. The change in mitochondria morphology during adipogenesis was not 
affected by long-term ethanol or acetaldehyde treatment. These data suggest that autophagy is 
required for the proper adipogenesis of cultured 3T3-L1 cells, which is associated with dynamic 
mitochondrial remodeling. 
In summary, I characterized the effect of chronic-plus-binge alcohol treatment on adipose 
morphology, mTOR signaling and autophagy in mice. I demonstrated that chronic-plus-binge 
alcohol inhibited mTOR and increased autophagic flux and adipose tissue atrophy in mice. I 
further demonstrated that mice with chronic adipose tissue autophagy deficiency were more 
v 
resistant to alcohol-induced adipose atrophy. These data indicate that autophagy activation 
contributes to the adipose dysfunction induced by alcohol. In addition, I also demonstrated that A-
Atg5 KO mice were more resistant to alcohol-induced liver injury likely due to the increased 
secretion of adiponectin and FGF21 at the basal levels of A-Atg5 KO mice. These data thus 
support an important role of adipose-liver axis in the pathogenesis of ALD. These studies further 
support the notion that targeting adipose tissue autophagy may be helpful in improving alcohol-
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CHAPTER 1. INTRODUCTION 
This chapter has been previously published as two separate articles and is reprinted here with 
adaptations and new material with permission. The original articles were cited as: 
 
Li, Y., S. Wang, H. M. Ni, H. Huang and W. X. Ding (2014). “Autophagy in Alcohol-Induced 
Multiogran Injury: Mechanisms and Potential Therapeutic Targets.” Biomed Res Int 2014: 
498491. 
(Li et al. 2014) 
Li, Y. and W. X. Ding (2017). “Adipose Tissue Autophagy and Homeostasis in Alcohol-Induced 
Liver Injury.” Liver Res 1(1): 54-62. Creative Commons license: 
https://creativecommons.org/licenses/by-ncnd/4.0/. 
(Li and Ding 2017) 
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1.1 Adipocytes and Adipose Tissues 
In mammals, adipose tissues or fat tissues are mainly categorized into white adipose tissue 
(WAT) and brown adipose tissue (BAT) which have distinct origin, morphology and functions. 
Adipocytes, also known as lipocytes or fat cells, are the predominant cells composing adipose 
tissues. Adipocytes are found not only in stereotypical fat depots but also in other locations like 
loose connective tissues. Here we mainly discuss adipocytes in adipose tissue. 
1.1.1 White Fat 
White adipocytes mainly originate from myogenic factor 5 (Myf5)-negative progenitors (Seale 
et al. 2008) and in adulthood from endothelial cell lines (Tran et al. 2012). Later evidence suggests 
that a small subset of white adipocytes originate from Myf5-positive progenitors (Sanchez-
Gurmaches et al. 2012, Shan et al. 2013). White adipocytes are characterized by a single large 
lipid droplet (LD), and a nucleus and scarce cytoplasm squeezed into the rim of cells (Fig.1.1.1A).  
The main function of WAT is to store energy in the form of LD. When there is sufficient 
nutrient intake, the insulin receptor on WAT is activated by insulin released from pancreas, which 
leads to a dephosphorylation cascade and inactivates hormone-sensitive lipase (HSL), favoring 
storage of triglycerides (TGs) in LDs. When the body needs energy, the stored TGs break down 
to fatty acids (FAs), which are taken up by muscle and cardiac tissue as a fuel source. The 
breakdown of TGs also generates glycerol, which is taken up by the liver for gluconeogenesis. 
WAT also has other important roles such as a thermal insulator helping to maintain body 
temperature (Alexander et al. 2015); a hormone receptor in response to insulin (Bluher et al. 2002), 
growth hormone (Berryman et al. 2011), norepinephrine (White and Engel 1958), and 
glucocorticoids (MacDougald et al. 1994); and an endocrine organ secreting adipokines including 
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adiponectin (Maeda et al. 1996), leptin (Zhang et al. 1994), resistin (Steppan et al. 2001), and 
apelin (Boucher et al. 2005). Obesity and overweight are usually accompanied with increased size 
and number of white fat cells. WAT is further categorized as subcutaneous WAT (sWAT) and 
visceral WAT based on its location (Chau et al. 2014). It is believed that visceral WAT is more 




Figure 1.1.1 Subcellular structure of adipocytes.  
Representative electron microscopy (EM) images of mouse (A) epididymal white adipose tissue 
and (B) interscapular brown adipose tissue. N, nucleus; LD, lipid droplet; asterisk, mitochondria. 
Scale bar: 2 μm. 
Figure 1.1.1 
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1.1.2 Brown Fat 
Brown adipocytes originate from Myf5-positive progenitors (Seale et al. 2008), and in 
adulthood also from endothelial precursors (Tran et al. 2012) and skeletal muscle stem cells 
(stellate cells) (Schulz et al. 2011). Patrick Seale and his colleagues led a series of studies showing 
that a transcriptional regulator PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16) 
determines the differentiation of brown adipocytes and is essential for maintaining BAT 
functions (Seale et al. 2007, Kajimura et al. 2008, Seale et al. 2008, Chi and Cohen 2016). 
Brown adipocytes are featured by numerous smaller LDs, considerable cytoplasm, and a large 
amount of mitochondria (Fig.1.1.1B). There are abundant capillaries in BAT to provide oxygen 
and distribute heat. 
Abundant in newborns and hibernating mammals, BAT dissipates energy and generates body 
heat by non-shivering thermogenesis. This process depends on a membrane protein uncoupling 
protein 1/thermogenin (UCP1) (Matthias et al. 2000). UCP1 increases the inner mitochondrial 
protein permeability, decreases the mitochondria proton gradient, and thus enables the energy from 
nutrient (e.g. FA) oxidation to generate heat rather than synthesize adenosine triphosphate (ATP). 
In human studies, enhanced cold-induced BAT activity is correlated with less adiposity and better 
glucose metabolism (van Marken Lichtenbelt et al. 2009, Matsushita et al. 2014). Therefore, BAT 
is considered an intriguing target of anti-obesity and anti-diabetes therapies. 
 
1.1.3 Beige Fat 
Early studies reported that some brown adipocytes appeared in WAT, which were later named 
as beige/brite adipocytes (Harms and Seale 2013). Though located in WAT and sharing the same 
6 
origin with white adipocytes, beige adipocytes have multilocular LDs, high mitochondrial content 
and brown-specific gene expression including UCP1. In response to cold or β-adrenergic agonists, 
beige adipocytes are induced and demonstrate thermogenic capacity (Bartelt and Heeren 2014). 
Stimulating the activity of beige adipocytes may offset the dysregulated WAT and improve the 
status of metabolic diseases. There is also emerging research interest in the interconversion 
between white adipocytes and beige adipocytes (Cinti 2009). The white-to-brown conversion in 
fat is often called “browning”. 
Besides adipocytes, there are other cell types in adipose tissue contributing to adipose growth 
and function, including preadipocytes, macrophages, lymphocytes, fibroblasts and vascular cells. 
Preadipocytes, also known as adipose progenitor cells, are important in controlling adipocyte 
number especially in context of obesity and diabetes (Rodeheffer et al. 2008). Macrophage 
accumulation in fat tissue contributes to systemic inflammation and insulin resistance (Weisberg 
et al. 2003, Xu et al. 2003). In WAT most of the infiltrating macrophages surround dead adipocytes 
and form crown-like structures (Murano et al. 2008).   
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1.2 Adipogenesis 
Adipogenesis is the differentiation process of fibroblast-like preadipocytes into lipid-rich, 
insulin-responsive, and adipokine-secreting adipocytes. Adipogenesis has been widely studied 
since 1970s (Green and Kehinde 1975), and people’s understanding of this complicated, integrated 
process is still developing. Most of the knowledge about adipogenesis comes from in vitro models 
which partially correlates with adipose development in vivo (Soukas et al. 2001). This process is 
generally described as two phases: the determination phase in which pluripotent stem cells convert 
into preadipocytes and lose the potential to differentiate into other types of cells (e.g. osteogenesis, 
chondrogenesis, neurogenesis, angiogenesis), and the terminal differentiation phase in which 
preadipocytes gradually acquire the morphology and function of mature adipocytes. The terminal 
differentiation phase is studied more since some of the cellular models of adipogenesis are 
preadipocyte lineages without the multipotency to differentiate into other types. The 
differentiation process involves a set of transcriptional regulation, and the most important 
regulators include peroxisome proliferator-activated receptor-gamma (PPAR-γ) (Brun et al. 1996) 
and CCAAT-enhancer-binding proteins (C/EBPs) (Darlington et al. 1998). A mixture of hormonal 
inducers are usually applied to induce adipogenesis in cellular models (Rosen and MacDougald 
2006). 3T3-L1, a mouse preadipocyte cell line is the most common model to study adipogenesis 
in vitro. Adipose-derived stromal cells, bone marrow stromal cells, embryonic stem cells, and 
mouse embryonic fibroblasts (MEFs) have also been used for similar purpose as primary cell 
culture models, though the differentiation requirement and time varies (Ruiz-Ojeda et al. 2016).  
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1.3 Autophagy in Adipose Tissue 
1.3.1 Overview of Autophagy 
Autophagy is a highly conserved, genetically programmed lysosomal degradation pathway to 
maintain cellular homeostasis. Depending on the delivery routes of cargo there are three types of 
autophagy: marcoautophagy, microautophagy, and chaperon-mediated autophagy (CMA).  
Microautophagy is constitutively active and autophagy gene-independent, which directly traps 
cytoplasmic components by invagination or budding of the surface of lysosomes (in mammals) 
/vacuoles (in yeast) (Mijaljica et al. 2011, Li et al. 2012). Microautophagy is usually non-selective 
but can be selective in the case of micropexophagy (Farre and Subramani 2004), piecemeal 
microautophagy of the nucleus (micronucleophagy) (Roberts et al. 2003), and micromitophagy 
(Lemasters 2014). 
CMA is chaperon-dependent selection of cytosolic proteins targeted for lysosomal degradation 
without formation of additional vesicles (Kaushik and Cuervo 2018). KFERQ-like motif-bearing 
proteins are recognized and delivered to lysosomes by chaperon heat shock cognate 71 kDa protein 
(HSC70) and other cochaperons. Their internalization in lysosomes depends on lysosome-
associated membrane protein 2A (LAMP2A), which is identified in birds and mammals (Gough 
et al. 1995). 
Macroautophagy (hereafter referred to as autophagy) involves the formation of a double-
membrane autophagic vesicle. Autophagy is regulated by more than 40 autophagy-related (Atg) 
genes that have been so far identified, which generally involves the following key steps as 








Figure 1.3.1 Schematic of the autophagy process. 
Autophagy is tightly regulated by a series of autophagy-related genes. Upon nutrient 
deprivation, mTOR inhibition or increased activity of AMPK activates the ULK1 complex 
followed by activation of the Beclin 1/VPS34 complex. This results in PI3-P enrichment in the 
autophagosome initiation site and recruitment of additional Atg proteins. Atg9L delivers 
membranes from other cell organelles, such as Golgi bodies, to supply the membranes. The 
double membrane or isolation membrane expands and encloses cell organelles, misfolded 
proteins, or xenobiotics. The two ubiquitin systems, the Atg7-Atg3-Atg8/LC3 and Atg12-Atg5-
Atg16L1 complexes, as well as Atg4 regulate the lipidation of LC3, which is essential for 
membrane elongation. The autophagosomes fuse with lysosomes to form autolysosomes, and 
this process is primarily mediated by Rab7, lysosome-associated membrane protein 1/2, STX17.  
The enwrapped cargos in autophagosomes then are degraded in the autolysosomes by lysosomal 
hydrolases. The outer membrane LC3 is de-conjugated by Atg4, while the inner membrane LC3 
is digested together with autophagy cargo in autolysosomes. G, glycine; E1, E1 ligase; E2, E2 
ligase; E3, E3 ligase. 
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1) Initiation, a process that is regulated by the complex that includes Unc-51 like kinase 1 
(ULK1)-FAK family-interacting protein of 200 kDa (FIP200)-Atg13. This complex is negatively 
regulated by the nutrient sensor the mechanistic target of rapamycin complex 1 (mTORC1) and 
positively regulated by the energy sensor Amp-activated protein kinase (AMPK) (Chang and 
Neufeld 2009, Hosokawa et al. 2009, Egan et al. 2011, Ding 2015). 
2) Nucleation, which requires the endoplasmic reticulum (ER)-resident SNARE protein 
syntaxin 17 (STX17) that further recruits Atg14L to the rough ER or ER-mitochondria contact 
site, and Atg14L then recruits Beclin 1 and Vps34 to the autophagosome initiation site on the 
rough ER (Matsunaga et al. 2010, Hamasaki et al. 2013). Vps34 is the mammalian class-III PI3 
kinase that promotes the generation of phosphatidylinositol 3-phosphate (PI3-P), which further 
recruits PI3-P effectors such as double FYVE domain-containing protein 1 (DFCP1), WD-repeat 
interacting protein with phosphoinositide 1 (WIPI1) and WIPI2 to initiate the biogenesis of 
autophagosomes (Proikas-Cezanne et al. 2004, Axe et al. 2008, Polson et al. 2010). Activating 
molecule in Beclin1-regulated autophagy (Ambra1) (Fimia et al. 2007), UV irradiation resistance-
associated gene (UVRAG) (Liang et al. 2006), and Bif-1/Endophilin B1 (Takahashi et al. 2007) 
positively regulate this complex, whereas Bcl-2 (Pattingre et al. 2005), Bcl-xL, Run domain 
protein as Beclin 1 interacting and cysteine-rich containing (Rubicon) (Zhong et al. 2009, Sun et 
al. 2011), AKT, and epidermal growth factor receptor (EGFR) negatively regulate this complex;  
3) Elongation, as the two ubiquitin-like conjugation systems, Atg7 (E1-like)-Atg3 (E2-like)- 
and the Atg12-Atg5-Atg16L1 complex (E3 ligase-like) regulate conjugation of 
phosphatidylethanolamine with microtubule-associated light chain (LC3) (called LC3-II), which 
expands the autophagosome membrane (Mizushima et al. 1998, Ichimura et al. 2000, Ohsumi 
2001). Atg9, the only Atg protein that has transmembrane domains, also delivers membranes from 
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trans-Golgi network/endosomes to the site of autophagosome biogenesis in an ULK1-and Vps34-
dependent manner to promote the elongation of the autophagosome membrane (Young et al. 
2006). It should be noted that the Atg12-Atg5-Atg16L complex generally transiently attaches to 
the autophagosomal membranes and is later dissociated from the autophagosomal membranes 
(Itakura and Mizushima 2010). This is in contrast with LC3-II that is relatively stable on the 
autophagosome membranes till the fusion of the autophagosomes with lysosomes. 
4) Closure, the mechanisms by which the autophagsome membranes fuse with each other and 
eventually form a complete enclosed double membrane vesicle are still not completely understood 
yet. However, work from Dr. Ohsumi’s lab has shown that LC3-II protein has the hemifusion 
function in vitro, which may help to tether the autophagosome membranes resulting in eventual 
closure of the autophagosome (Nakatogawa et al. 2007). It should also be noted that PI3-P is also 
dephosphorylated locally by the phosphatases myotubularin-related protein 3 (MTMR3, also 
called Jumpy) upon closure of the autophagosomes (Vergne et al. 2009, Taguchi-Atarashi et al. 
2010).  
5) Finally, autophagosomes fuse with lysosomes to form autolysosomes, which is mediated by 
Ras-related protein 7 (Rab7), LAMP1/2 and STX17 (Jager et al. 2004, Huynh et al. 2007, Itakura 
et al. 2012). After fusion, the outer membrane of LC3-II is deconjugated from the autolysosomal 
membrane by Atg4B, and the inner membrane LC3-II is degraded together with autophagosome 
cargos by lysosomal proteases (Mizushima et al. 2002, Tanida et al. 2004). 
Depending on the targets, autophagy can be categorized into non-selective bulk autophagy and 
selective autophagy. Non-selective autophagy breaks down proteins and organelles to provide the 
cell with nutrients in response to starvation (Mizushima 2007). Selective autophagy removes 
damaged and excess organelles as well as protein aggregates using specific receptors in both 
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nutrient-sufficient and poor conditions as well as other pathophysiological conditions such as 
exposure to xenobiotics or drugs (Ding and Yin 2012, Stolz et al. 2014, Williams et al. 2015, Ni 
et al. 2016, Yang et al. 2016). It should be noted that the different types of autophagy mentioned 
above can coexist in cells and are not mutually exclusive. 
Due to the complex dynamic nature of the autophagic process, it is very challenging to monitor 
autophagy in a quantitative way, in particular in vivo in whole animal tissues/organs. While LC3-
II is widely used to monitor the autophagic process, LC3-II itself is also degraded in the 
autolysosomes. Thus an autophagic flux assay, which monitors LC3-II levels with or without a 
lysosomal inhibitor such as chloroquine (CQ) or bafilomycin A1 (BAF), has been recommended 
to determine autophagy status by the autophagy research community (Klionsky et al. 2016). In 
addition, the level of p62/sequestosome 1 (SQSTM1) has also been suggested to use as another 
marker for autophagic flux because p62/SQSTM1 is normally degraded in response to starvation 
and accumulated in genetic autophagy gene deleted mouse livers (Komatsu et al. 2010, Ni et al. 
2012). However, the levels of p62/SQSTM1 may not always be suitable to monitor autophagic 
flux because its levels are also regulated at the transcriptional level, which is often induced in 
many experimental autophagy models including prolonged starvation conditions (Sahani et al. 
2014). 
 
1.3.2 Autophagy and Lipid Metabolism 
LD formation is an indispensable step of lipid metabolism. The Atg8/LC3 conjugation system 
is essential for autophagosome membrane formation but some evidence suggests that Atg8/LC3 
conjugation is also involved in LD formation. Indeed, LD formation is suppressed in autophagy-
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deficient hepatocytes (Shibata et al. 2009). As discussed above, the ubiquitin-like protein Atg8 
also mediates the tethering and hemifusion of liposomes (Nakatogawa et al. 2007). However, it is 
not clear whether Atg8/LC3 is required for LD-LD fusion. Using Atg5 knockout (KO) and Atg7 
KO MEFs that were loaded with oleic acid, we found that LD still formed in Atg5 KO and Atg7 
KO MEFs and there was no difference for the number of LDs between wild-type (WT) cells and 
these KO cells. These data clearly indicate that LC3-II is dispensable for the LD formation (Li et 
al. 2018). 
Notably, TGs and cholesterol in LDs could also be taken up by autophagosomes and delivered 
to lysosomes for degradation by acidic hydrolases through selective autophagy. This alternative 
pathway of lipid metabolism has been described and termed as lipophagy (Singh et al. 2009, Singh 
and Cuervo 2012), in contrast to the usual pathway via cytoplasmic neutral hydrolases. Autophagic 
removal of excess hepatic LDs has been shown in mice that were fed with high fat diet or challenge 
with alcohol, two common causes that induce non-alcoholic fatty liver disease (NAFLD) and 
alcoholic fatty liver disease (Singh et al. 2009, Ding et al. 2010). Impaired lipophagy in liver 
exacerbates fatty liver disease (Martinez-Lopez and Singh 2015). In contrast, activation of 
autophagy attenuates fatty liver in both NAFLD and alcoholic fatty liver disease (Ding et al. 2010, 
Lin et al. 2013, Park et al. 2014). How autophagy selectively removes excess LDs is still largely 
unknown. A recent study showed that the small guanosine triphosphatase (GTPase) Rab7 is 
indispensable for LD breakdown in hepatocytes subjected to nutrient deprivation. Starvation 
activates Rab7 that promotes trafficking of both multivesicular bodies and lysosomes to the LD 
surface during lipophagy, resulting in the formation of a lipophagic synapse. Genetic knockdown 
of Rab7 leads to gross morphological changes of multivesicular bodies, lysosomes, and 
autophagosomes, resulting in the attenuation of hepatocellular lipophagy (Schroeder et al. 2015). 
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Future studies are needed to determine whether other autophagy receptor proteins such as 
p62/SQSTM1 are involved in selective lipophagy. Surprisingly, under starvation conditions, WT 
mice have increased accumulation of hepatic LDs, whereas liver autophagy-deficient mice (such 
as liver-specific Atg5, Atg7 and FIP200 KO) do not. These data suggest that some secondary 
effects in these mice may either affect the uptake of FAs from the blood or compensatory 
alternative LD breakdown pathways may be active in these autophagy-deficient mouse livers (Ma 
et al. 2013, Wang et al. 2014, Li et al. 2018). 
In addition to autophagy (macroautophagy), CMA regulates LD biology and in the 
maintenance of lipid homeostasis. CMA specifically degrades the LD-associated proteins perilipin 
(PLIN) 2 and PLIN3 prior to lipolysis. AMPK phosphorylates PLIN2 and primes PLIN2 for its 
degradation by CMA (Kaushik and Cuervo 2016). Inhibition of CMA leads to decreased 
association of adipose triglyceride lipase (ATGL) and lipophagy-related proteins with LDs 
resulting in decrease in lipid oxidation and accumulation of LDs (Kaushik and Cuervo 2015). In 
addition to macroautophagy and CMA, lysosome itself can also directly envelop cargos for their 
degradation via microautophagy. However, the significance for microautophagy for LDs and lipid 
homeostasis is still largely elusive.  
 
1.3.3 Autophagy and Adipogenesis In Vitro 
Adipocytes derive from multipotent mesenchymal stem cells and require massive cytoplasmic 
remodeling. During adipogenesis of primary MEFs, the levels of LC3-II increase and 
p62/SQSTM1 protein decrease together with increased autophagic structures enclosing 
mitochondria and other organelles, indicating enhanced autophagy (Baerga et al. 2009). Emerging 
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evidence in cells and transgenic mice suggests that some genes critical in autophagy process affect 
mass, differentiation and physiological functions of adipose tissue. The notion is supported by the 
following evidence: 1) Atg5 or Atg7 deficiency impairs adipogenesis in vitro and in vivo (Baerga 
et al. 2009, Singh et al. 2009, Zhang et al. 2009); 2) treatment of CQ, an autophagy inhibitor that 
increases lysosomal pH, inhibits adipogenesis in vitro (Baerga et al. 2009, Singh et al. 2009); 3) 
mice with deletion of p62, an autophagy substrate, develop mature-onset obesity and insulin 
resistance (Rodriguez et al. 2006). Interestingly, upregulated autophagy proteins and genes have 
also been observed in human adipose tissue samples in obesity although no autophagic flux data 
are available in obese human adipose tissue (Kovsan et al. 2011). The role of autophagy in adipose 
tissue especially in disease context thus still needs to be further investigated. 
Mechanistic target of rapamycin (mTOR), a highly conserved serine-threonine protein kinase, 
is a key regulator of cell growth and metabolism. As discussed above, mTOR complex 1 (mTOR1) 
is a negative regulator at the preinitiation complex to regulate the initiation of autophagosome 
biogenesis (Yang and Klionsky 2010). Pharmacological and genetic evidence has proved that 
mTORC1 is required for adipogenesis and adipose maintenance in vitro (Kim and Chen 2004, 
Polak et al. 2008). Activation of mTOR suppresses lipolysis, stimulates lipogenesis, and promotes 
fat storage (Chakrabarti et al. 2010). The phenotypes observed from the activation of mTOR in 
adipocytes would be difficult to reconcile with the phenotypes from the adipocyte-specific Atg5 
or Atg7 KO mice because one would assume that activation of mTOR would lead to decreased 
autophagy. However, there are some distinctive differences here. Unlike adipocyte-specific Atg5 
or Atg7 KO mice, activation of mTOR may not be able to completely eliminate autophagy. In 
addition, autophagy can also occur independent of mTOR (Li et al. 2016). Therefore whether 
autophagy is involved in mTOR-regulated adipocyte biology remains to be further investigated.  
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1.3.4 Autophagy and Remodeling of Beige Adipocytes 
As briefly mentioned above, beige adipocytes, also called the browning of white fat, are 
recently discovered as a distinct type of thermogenic fat to exert anti-obesity effects by burning 
FA and glucose instead of storing lipids (Peirce et al. 2014). Both beige adipocytes and the 
traditional brown adipocytes are competent for thermogenesis through the actions of UCP1 and 
share similar morphological characteristics such as multilocular LDs and abundant mitochondria. 
Beige adipocytes are inducible and derived from white adipocytes in response to cold stress or 
pathways that elevate intracellular cyclic adenosine monophosphate (cAMP) (Bartelt and Heeren 
2014). Interestingly, the “browning of white” process is reversible and beige adipocytes can return 
to white adipocytes by removing excess mitochondria likely via selective autophagy for 
mitochondria (mitophagy). Indeed, a recent report provides strong evidence to support that 
autophagy pathway is crucial for mitochondrial clearance during the beige-white transition. 
Adipocyte-specific Atg5 or Atg12 KO mice prevent beige adipocyte loss after withdrawing 
external stimuli. These mice also maintain high thermogenic capacity and protect against diet-
induced obesity and insulin resistance (Altshuler-Keylin et al. 2016). Selective mitophagy is 
mediated by Pink1-Parkin pathway (Ding and Yin 2012, Ni et al. 2015, Pickrell and Youle 2015) 
but it remains unclear whether Pink1 or Parkin plays a role in mitophagy during the beige-white 
transition.  
 
1.3.5 Genetic Approaches to Study Autophagy in Adipose Tissue 
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Since autophagy is involved in development and many biological processes, and whole-body 
autophagy KO may be lethal (Kuma et al. 2004), tissue-specific KO system is preferable if genetic 
autophagy inhibition is desired in autophagy study. The Cre/LoxP site-specific recombination 
system which inactivates specific genes in fat has been widely applied in mice to study adipocyte 
functions. A commonly used promoter is adipocyte protein-2 (aP2) gene encoding fatty acid-
binding protein-4 (Fabp4). However, the specificity of aP2 deletion has not been satisfying, as 
Fabp4 also expresses in heart, skeletal muscle, and testis (Lee et al. 2013, Jeffery et al. 2014). The 
promoter cassette of Adipoq gene encoding adiponectin has been proved to be more specific for 
adipocytes (Wang et al. 2010), and have been used more frequently in recent years. Since UCP1 
is predominantly expressed in BAT and brown adipocytes, Ucp1-Cre can be used in study focused 
in brown adipocytes and beige adipocytes (Guerra et al. 2001, Altshuler-Keylin et al. 2016). As 
discussed in 1.3.1, autophagy is tightly regulated by a series of genes. Up-to-date in vivo studies 
on adipose autophagy using transgenic models are summarized in Table 1. Since autophagy can 
be activated by mTOR inhibition, transgenic mice modulating mTOR in adipose tissue may also 
affect autophagy (Table 2).   
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p62 Whole body Mature-onset obesity; insulin resistance (Rodriguez et al. 
2006) 
Atg5 Whole body Fewer sWAT cells in neonatals pups  (Baerga et al. 2009) 
Atg5, 
Atg12 
Ucp1-Cre Inhibited beige-to-white conversion; higher thermogenic 




Atg7 aP2-Cre Reduced body weight and WAT mass; increased 
multilocular adipocytes and mitochondria content in WAT; 
increased physical activity; increased insulin sensitivity; 
resistance to high fat diet (HFD)-induced obesity 
(Singh et al. 2009, 





Aggravated insulin resistance; increased inflammasome 
activation 
(Lim et al. 2014) 
Bif1 Whole body Obesity; insulin resistance; impaired lipid catabolism (Polak et al. 2008, 
Liu et al. 2016) 
Pik3c3 aP2-Cre With aging: Reduced adiposity; improved glucose 
tolerance; increased browning 
(Lee et al. 2016, 
Ghosh et al. 2018) 
 




Raptor aP2-Cre Reduced body weight and fat mass; increased browning; 
increased energy expenditure due to uncoupling respiration 
in WAT; improved metabolic parameters; resistance to 
HFD-induced obesity 
(Polak et al. 2008) 
 
Adipoq-Cre Reduced fat mass with aging; fatty liver; insulin intolerance; 
resistance to HFD-induced obesity but more severe hepatic 
steatosis; impaired lipid absorption 
(Lee et al. 2016) 
TSC1 aP2-Cre Whitening in BAT (Xiang et al. 2015) 
 
Adipoq-Cre Reduced visceral fat adiposity; increased browning; 
increased diet-induced glucose tolerance 
(Magdalon et al. 
2016) 
mTOR Adipoq-Cre Reduced fat mass; impaired BAT development; increased 
browning; impaired insulin resistance 
(Shan et al. 2016) 
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To study adipocyte function in vitro, researchers have used primary MEFs and adipose-
derived stromal vascular fraction cells (SVFs) isolated from mice. These are preadipocytes, i.e. 
they can be differentiated into adipocyte-like cells under the exposure to hormonal inducers. 
Primary preadipocytes isolated from KO mice are a powerful tool to genetically modulate 
autophagy in studying adipogenesis. However, these cells lose the adipogenic potential and 
become senescent after a few passages. 
3T3-L1 cell line is another type of mouse preadipocytes that is commonly used for the 
studying of adipogenesis in vitro (Green and Kehinde 1975). They can be passed for over 10 
passages, and are more suitable for small interfering RNA (siRNA) or small hairpin RNA (shRNA) 
transfections, but not suitable for adeno-associated virus (AAV) infection unless coxsackie and 
adenovirus receptors (CARs) are introduced (Orlicky and Schaack 2001). Abundant evidence 
proves that autophagy and mTOR signaling is essential for adipogenesis in vitro (Table 3 & 4). 
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Table 3 In vitro adipogenesis studies genetically modulating autophagy 
Gene Cell type  Phenotypes References 
p62 -/- pMEFs Enhanced adipogenesis (Rodriguez et al. 2006) 
Atg5 3T3-L1 cells Impaired adipogenesis (Singh et al. 2009) 
 
-/- or +/- pMEFs Impaired adipogenesis (Baerga et al. 2009, 
Zhang et al. 2013) 
Atg7 3T3-L1 cells Impaired adipogenesis (Singh et al. 2009) 
 
-/- pMEFs Impaired adipogenesis (Zhang et al. 2009) 
Atg4b 3T3-L1 cells Impaired differentiation (Guo et al. 2013) 
Ulk1, 
Ulk2 
3T3-L1 cells Decreased mitochondria respiration and ATP 
production; opposing effect on lipid metabolism 
and glucose uptake 
(Ro et al. 2013) 
pMEFs: Primary mouse embryonic fibroblast 
Table 4 In vitro adipogenesis studies genetically modulating mTOR 
Gene Cell type Phenotypes References 
Raptor 3T3-L1 cells Impaired adipogenesis and adipose maintenance; 
increased lipolysis  
(Polak et al. 2008) 
Tsc2 -/- pMEFs Enhanced adipogenesis (Chakrabarti et al. 2010) 
Tsc1 Brown preadipocytes 
from aP2-Cre KO 
mice 
Brown-to-white conversion (Xiang et al. 2015) 
mTOR Brown preadipocytes 
from Adipoq-Cre KO 
mice  
Impaired differentiation (Shan et al. 2016) 
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1.4 Alcohol-induced Multi Organ Injury 
Chronic or acute alcohol abuse often leads to liver injury associated with alcoholic hepatitis, 
liver fibrosis, cirrhosis and liver cancer (Gao and Bataller 2011). In addition to the liver, alcohol 
abuse also induces a variety of other tissue injuries including pancreatitis (Gukovsky et al. 2008, 
Gu et al. 2013), cardiomyopathy (Ren and Wold 2008, Piano and Phillips 2014), neurotoxicity 
(Harper 2009), muscle loss (Lang et al. 2004), impaired immune functions (Gao and Bataller 
2011), endocrine and fetal abnormalities (Pruett et al. 2013), and osteoporosis (Maurel et al. 2012). 
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), more than 18 
million adults are affected by alcoholism in the United States, which costs 27 billion dollars for 
treating alcohol-attributable diseases.  
The mechanisms for alcohol-induced detrimental effects in various tissues/organs have been 
extensively studied, which involves genetic and environmental factors as well as altering multiple 
cellular signaling pathways. These mechanisms involve ethanol and its metabolites that induce 
reactive oxygen species (ROS) generation, lipid peroxidation, cytokine expression/inflammation, 
organelle damage and stress, and activate both apoptotic and necrotic cell death pathways (Molina 
et al. 2002). However, the full picture, especially the cellular adaptive and protective mechanisms 
against ethanol-induced stress and tissue injury have not been well-depicted yet. Currently, the 
treatment for chronic alcohol diseases is not very effective owing largely to our incomplete 
understanding of the cellular adaptive response to ethanol toxicity.  
Accumulating evidence has shown that altered autophagy is implicated in the pathogenesis 
and protection of ethanol-induced tissue injury (Ding et al. 2011, Dolganiuc et al. 2012, Czaja et 
al. 2013). This section aims to summarize current knowledge about the role of autophagy in 
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alcohol-induced injury in multiple tissues/organs and their underlying molecular mechanisms. 
Potential therapeutic targets based on modulation of autophagy will also be discussed. 
 
1.4.1 Alcohol Metabolism and Its Effect on Tissue Injury 
Ethanol is metabolized through several pathways. Predominantly alcohol is metabolized by 
alcohol dehydrogenase (ADH) into acetaldehyde, a highly toxic byproduct, and then by aldehyde 
dehydrogenase (ALDH) into acetate, a less harmful substance. The most important two isoforms 
of ALDH is the cytosolic ALDH1 and the mitochondrial ALDH2 (Crabb et al. 2004). The 
oxidation mainly occurs in liver (Lieber et al. 1975), but also in pancreas (Vonlaufen et al. 2007), 
heart (Ren and Wold 2008), and other organs (Zakhari 2006), accompanied by conversion of 
nicotinamide adenine dinucleotide (NAD+) into its reduced form, NADH, which plays several 
critical roles in redox metabolism. Besides, ethanol can also be metabolized by cytochrome P450 
family 2, subfamily E, polypeptide 1 (CYP2E1) and catalase. Excessive ethanol exposure largely 
induces CYP2E1, which not only mediates and activates reactions of many toxicological 
substrates, but also generates ROS leading to cellular damage (Lu and Cederbaum 2008). 
Additionally, ethanol could interact with FA and generate FA ethyl ester (FAEE) catalyzed by 
FAEE synthase in many tissues and organs in a non-oxidative pathway (Zelner et al. 2013). FAEE 
was thought to have a minor effect and mainly considered as a diagnostic marker, but accumulated 
evidence shows that FAEE exacerbates injury after ethanol exposure especially in pancreas 
(Werner et al. 2002, Wu et al. 2008), liver (Wu et al. 2006) and heart (Beckemeier and Bora 1998, 
Wu et al. 2006, Wu et al. 2008), and is facilitated by ADH deficiency (Bhopale et al. 2006). One 
explanation of cytotoxicity of FAEE is that FAEE binds to mitochondria membrane and with its 
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hydrolysis products, FAs, causes damage by uncoupling oxidative phosphorylation (Lange and 
Sobel 1983). 
Alcohol is easily absorbed and could be metabolized and impact on almost all over the body. 
Matured brain is less affected compared with developing brain due to the blood-brain barrier, but 
excessive oxidative stress and intracellular Ca2+ release induced by ethanol could impair the barrier 
function (Haorah et al. 2007). Dysregulated metabolites lead to changes in carbohydrate 
metabolism, cell death signaling, mitochondria permeability transition and epigenetic regulation 
(Zakhari 2013). Apoptosis and necrosis induced or exacerbated by alcohol metabolism have been 
studied in liver (Nanji and Hiller-Sturmhofel 1997, Ishii et al. 2003), pancreas (Gukovskaya et al. 
2006, Wang et al. 2006), heart, brain (mostly developing brain) (Johansson et al. 2009, Alfonso-
Loeches et al. 2010) (Olney et al. 2002) and skeletal muscle (Fernandez-Sola et al. 2003). Recent 
evidence has also showed the involvement of necroptosis, the receptor interacting protein (RIP)-
mediated non-apoptotic cell death pathway in the pathogenesis of alcoholic liver disease (ALD) 
(Roychowdhury et al. 2013). The effect of metabolites in different tissues/organs will be further 
discussed below. 
 
1.4.2 Autophagy in Alcohol-induced Liver Injury 
ALD is a major cause of morbidity and mortality worldwide. The spectrum of ALD ranges 
from steatosis, inflammation, fibrosis, and cirrhosis to hepatocellular carcinoma (Altamirano and 
Bataller 2011, Williams et al. 2014). In liver, ethanol is mainly metabolized by ADH, catalase and 
CYP2E1, which promotes the generation of ROS and other reactive toxic metabolites leading to 
tissue injury (Lieber et al. 1975, Lu and Cederbaum 2008).  
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Notably, liver plays a key role in lipid metabolism, and hepatocytes take up free fatty acids 
(FFAs) and convert them to TGs for storage with cholesterol in LDs (Martinez-Lopez and Singh 
2015). Several mechanisms could contribute to ethanol-induced steatosis: enhanced lipid synthesis 
by activated transcription factor sterol regulatory element binding protein-1 (SREBP-1), decreased 
FA oxidation by downregulated nuclear receptor PPARα or mitochondria damage, decreased very 
low density lipoprotein (VLDL) secretion, promoting effect of activated transcription factor early 
growth response-1 (Egr-1), and changed levels of important humoral factors including adiponectin 
and tumor necrosis factor alpha (TNF-α) (Donohue 2007).  
Liver is one of the most active organs, which plays a central role in regulating the overall 
organism energy balance by controlling carbohydrate and lipid metabolism. Under physiological 
conditions, liver also serves as a major buffering system to ensure other tissues to function 
normally by maintaining the homeostasis of macro- and micronutrients. To accomplish these vital 
missions, liver may rely on autophagy, the cellular catabolic process to breakdown 
macromolecules, lipids and damaged/excess organelles. Indeed, liver-specific autophagy gene KO 
mice have disrupted metabolism of proteins, glucose and lipids, accumulated damaged and excess 
organelles such as mitochondria and peroxisomes, and results in increased cell death, 
inflammation, and liver tumorigenesis (Singh et al. 2009, Komatsu et al. 2010, Takamura et al. 
2011, Ni 2014). ALD also involves the disruption of cellular metabolism of proteins, lipids and 
homeostasis of organelles such as mitochondria and ER resulting in increased cell death that 
contributes to alcoholic hepatitis, liver fibrosis, cirrhosis and liver cancer (Gao and Bataller 2011, 
Williams et al. 2014). All these pathogenic events are intimately related to the autophagic process, 
and modulating autophagy may thus affect the ALD pathogenesis. Indeed, accumulating evidence 
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now indicates that autophagy plays a critical role in the pathogenesis of ALD (Ding et al. 2011, 
Dolganiuc et al. 2012, Czaja et al. 2013).  
Differential Autophagy Status in Acute and Chronic ALD Models  
Many animal models as well as in vitro cell culture models have been developed to study 
ALD. While baboons and pigs have been used to study ALD, rodents have been predominantly 
used in current ALD because of its lower cost and propensity for genetic modulation (Arteel 2010). 
The animal models for ALD include acute alcohol gavage (Carson and Pruett 1996), ad libitum 
oral alcohol in drinking water (Best et al. 1949), intragastric infusion (Tsukamoto-French model) 
(Tsukamoto et al. 1985), chronic Lieber-DeCarli diet ethanol feeding (DeCarli and Lieber 1967), 
and the most recent chronic-plus-binge model (Bertola et al. 2013).  
There are some controversial reports regarding the autophagy status in ALD research. The 
reasons behind these controversial reports are likely due to the complexity of autophagy assays 
and the use of many different ALD models. It is generally agreed that acute ethanol (binge) 
treatment increases autophagy in mouse livers and in primary cultured murine hepatocytes, a 
conclusion that is supported by autophagic flux data in these studies (Ding et al. 2010, Ni et al. 
2013). In contrast, impairment of autophagy has also been reported in ethanol-treated CYP2E1 
overexpressing HepG2 cells or in CYP2E1 knockin mice that were given acute alcohol twice a 
day for four days (Wu et al. 2010, Wu et al. 2012). However, only a decreased LC3-II/I ratio was 
observed and no autophagic flux assays were conducted in these studies. Using HepG2 cells that 
stably overexpressed both CYP2E1 and ADH, Thomes et al (Thomes et al. 2013) reported that 
ethanol treatment increased autophagosome synthesis but also impaired lysosomal degradation. 
However, the autophagic flux data in this study actually supported an increase in autophagy 
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(Thomes et al. 2013). Early works from the same group showed that ethanol treatment may 
increase lysosomal pH and impair cathepsin maturation (Kharbanda et al. 1995, Kharbanda et al. 
1997). Thus it is possible that increased autophagy by ethanol treatment may serve as a 
compensatory mechanism in response to ethanol-induced mild impaired lysosomal functions. In 
contrast to acute alcohol treatment, it has been generally thought that chronic alcohol consumption 
may have impaired autophagy in the liver because it has long been shown that chronic alcohol 
administration leads to hepatomegaly and protein accumulation in liver (Baraona et al. 1975, 
Donohue et al. 1989, Donohue 2009). In a chronic ethanol feeding study, Lin et al performed 
autophagic flux studies in mice that were fed an ethanol diet for 4 weeks and increased autophagic 
flux was found in that study (Lin et al. 2013). However, we should interpret these data cautiously 
since the autophagic flux assay was only performed at one time point after the 4 week feeding, 
while ideally, autophagic flux assays should be applied to multiple time points owing to the 
dynamic nature of autophagy. In addition, the autophagy status in other ALD models, such as the 
Tsukamoto-French model and the chronic-plus-binge model, has not been reported. Recent work 
from our lab showed that chronic feeding plus acute binge ethanol impaired transcription factor 
EB (TFEB), a master regulator of lysosomal biogenesis, resulting in decreased number of hepatic 
lysosomes and insufficient autophagy (Chao et al. 2018). Moreover, in addition to hepatocytes, 
whether and how ethanol would affect autophagy on other liver cells, such as hepatic stellate and 
Kupffer cells, and their impacts on ALD are largely unknown. Regardless of the controversies on 
autophagy status, it has been unanimously shown that activating autophagy is beneficial against 
ALD in various ALD models (Ding et al. 2010, Lin et al. 2013, Ni et al. 2013, Yang et al. 2014). 
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Possible Mechanisms Affecting the Autophagy Process Induced by Alcohol  
As discussed above, autophagy is a dynamic multi-step process that is tightly regulated by 
many signaling pathways involving nutrients, energy and stress response. Below we discuss the 
regulating pathways of autophagy that have been shown to be affected by alcohol. 
Class I PI3K-Akt-mTOR  
As discussed above, mTORC1 is a negative regulator at the pre-initiation complex to regulate 
the initiation of autophagosome biogenesis (Yang and Klionsky 2010). mTOR is part of two 
structurally and functionally different complexes, mTORC1 and mTORC2. The former complex 
is sensitive to rapamycin and plays a major role in regulation of cell growth and autophagy. 
mTORC1 is also a sensor of various signals including growth factors, insulin, nutrients, energy 
status and cellular stressors. In nutrient-sufficient condition, growth factors activate the class I 
phosphoinositol-3-kinase (PI3K) to catalyze PIP3 and subsequently activate Akt, which then 
further activates downstream mTORC1 and inhibits autophagy. mTORC2 may also negatively 
regulate autophagy because it is required for full activation of Akt (Facchinetti et al. 2008, Ikenoue 
et al. 2008). Suppression of Akt and mTOR are common mechanisms of autophagy induction, 
which is also affected by acute ethanol treatment. It has been demonstrated that acute ethanol-
treated mouse liver and chronic ethanol-treated rat liver has increased expression of phosphatase 
and tensin homolog (PTEN) resulting in the suppression of Akt (Yeon et al. 2003, He et al. 2007). 
We also found that acute ethanol treatment decreases the level of phosphorylated Akt in mouse 
liver (Ni et al. 2013). Besides, ethanol treatment inhibits mTORC1 activity in primary cultured 
mouse hepatocytes (Ding et al. 2010). More importantly, pharmacological inhibition of mTOR by 
either rapamycin or Torin 1 significantly suppresses acute ethanol-induced liver steatosis and 
injury (Ding et al. 2010, Czaja et al. 2013). More future studies are needed to further determine 
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the detailed time-course changes of mTOR and their associations with autophagy during chronic 
alcohol feeding.  
Interestingly, application of wortmannin, a specific PI3K/Akt inhibitor showed dual effects 
on acute ethanol-induced fatty liver depending on dose (Zeng et al. 2012). PI3K/Akt activation is 
known to enhance sterol regulatory element-binding protein-1 (SREBP-1)(Porstmann et al. 2008), 
and SREBP-1 coordinates autophagy-lysosomal activities and lipid metabolism (Jegga et al. 
2011). In this model, low dose of wortmannin alleviated the rise of hepatic TG possibly by 
inhibiting SREBP-1 via PI3K/Akt inhibition, while high dose of wortmannin aggravated the 
disease likely due to the block of autophagy. This suggests that special attention should be paid to 
the interpretation of use of PI3K/Akt inhibitor in alcohol-induced fatty liver models. 
AMPK 
AMPK is a key energy sensor that regulates cellular metabolism and energy homeostasis. 
AMPK can directly inhibit mTOR through increased phosphorylation of TSC2 (Inoki et al. 2003, 
Kim et al. 2011) and Raptor (Gwinn et al. 2008), which activates autophagy. AMPK also promotes 
autophagy by phosphorylating ULK1, Vps34 and Beclin1 (Egan et al. 2011, Kim et al. 2011, Kim 
et al. 2013). However, administration of an AMPK activator adenosine, 5-amino-4-imidazole 
carboxamide riboside (AICAR) suppresses autophagy in hepatocytes (Samari and Seglen 1998). 
Moreover, administration of compound C, an AMPK inhibitor, activates autophagy via AMPK-
independent blockade of the Akt/mTOR pathway, which overcomes the expected inhibitory effect 
on autophagy via AMPK inhibition in cancer cells (Vucicevic et al. 2011). Several lines of 
evidence show that AMPK activity is reduced in liver by ethanol consumption, which is believed 
to promote fatty liver through activation of SREBP-1 and up-regulation of lipin-1 expression (You 
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et al. 2004, Hu et al. 2012). The exact role of AMPK in ethanol-induced autophagy is not clear but 
it is possible that ethanol induces autophagy independent of AMPK activation.  
ADH, CYP2E1 and ROS 
In liver, ethanol is mainly metabolized by ADH and CYP2E1, which promotes the generation 
of ROS and other reactive toxic metabolites. Interestingly, ethanol-induced autophagy requires its 
metabolism and ROS production because autophagic flux was only induced in HepG2 cells stably 
expressing ADH and CYP2E1 but not in parental HepG2 cells (Ding et al. 2010, Thomes et al. 
2013). Moreover, blocking ADH and CYP2E1 by 4-methylpyrazole or inhibiting ROS by 
antioxidants also reversed the inhibition of mTOR and diminished increased green fluorescent 
protein (GFP)-LC3 puncta (Ding et al. 2010, Thomes et al. 2013). It seems that alcohol oxidation 
by CYP2E1 is also important for alcohol-induced inhibition of cellular proteasome activity and 
increased autophagosome numbers (Thomes et al. 2012). It has been proposed that ROS may 
activate autophagy through modulating the oxidization of Atg4, an autophagy machinery protein 
important for generating and recycling of LC3-II (Scherz-Shouval et al. 2007). As discussed above, 
studies from ethanol-treated HepG2 cells that are overexpressing Cyp2E1 and ethanol-treated 
Cyp2e1 KO or knockin mice showed decreased LC3-II levels (Wu et al. 2010, Wu et al. 2012, Wu 
and Cederbaum 2013, Yang et al. 2014). While the authors concluded that CYP2E1-mediated 
metabolism of ethanol may lead to inhibition of autophagy in these studies, autophagic flux assays 
were not conducted in these studies. Future studies are needed to further confirm the autophagy 
status in ethanol-treated Cyp2e1 KO or knockin mice by performing an autophagic flux assay.  
FoxO3 and SIRT1 
31 
Forkhead box-containing protein class O (FoxO) family of DAF-16 like transcription factors 
are evolutionarily conserved transcriptional factors that regulate the expression of genes involved 
in multiple cellular functions including oxidative stress, glucose metabolism, apoptosis, cell cycle 
transition as well as DNA repair (Huang and Tindall 2007, Tikhanovich et al. 2013). Four FoxO 
proteins including FoxO1, FoxO3, FoxO4 and FoxO6 are found in mammals, which have 
redundant yet distinctive roles in regulating gene expression. While FoxO1, FoxO3 and FoxO4 
are ubiquitously expressed in most tissues, FoxO6 is mainly expressed in neurons. Studies from 
gene KO mice show that FoxO1 KO mice are embryonically lethal due to impaired angiogenesis 
but FoxO4 KO mice are viable with decreased migration of vascular smooth muscle cells (Li et 
al. 2007). While FoxO3 KO mice are also viable, female mice are infertile due to ovarian activation 
and they also have spontaneous T cell activation and lymphoproliferation with time (Lin et al. 
2004). FoxO3 mainly regulates the expression of genes responsible for oxidative stress, apoptosis, 
cell cycle transition as well as DNA repair but FoxO1 is more important in regulating glucose and 
lipid metabolism. All the FoxO family proteins are subjected to multiple post-translational 
modifications, including phosphorylation, acetylation, methylation and ubiquitination 
(Tikhanovich et al. 2013). Akt-mediated phosphorylation of FoxO3 causes its nuclear exclusion 
and thus inactivates FoxO3. It seems that the acetylation of FoxO3 mainly regulates the specificity 
of a subset of FoxO3 target genes by increasing the expression of antioxidant genes and 
suppressing the expression of apoptosis genes in response to oxidative stress (Brunet et al. 2004), 
whereas methylation of FoxO3 at K270 results in loss of DNA binding (Xie et al. 2012).  
 Increasing evidence now suggests that FoxO family proteins can also regulate autophagy by 
three distinctive mechanisms: direct transcriptional regulation of Atg gene expression 
(Mammucari et al. 2007, Zhao et al. 2007), transcriptional regulation of glutamine synthetase 
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expression and increasing intracellular glutamine levels (van der Vos et al. 2012), and interaction 
of cytosolic FoxO1 with Atg7 independent of its transcription activity (Zhao et al. 2010).  
Sirtuin 1 (Sirt1) belongs to the evolutionarily conserved sirtuin family, which are NAD-
dependent class III protein deacetylases. There are 7 sirtuins (Sirt1-7) that have been identified in 
mammals, which have distinct cellular locations. Sirt1, 6 and 7 are mainly in the nucleus, Sirt2 is 
mainly in the cytosol and Sirt3, 4 and 5 are found in the mitochondria (Haigis and Sinclair 2010, 
Nakagawa and Guarente 2011). Sirt1 has a broad range of physiological functions including the 
control of aging, metabolism and gene expression by promoting the deacetylation of a variety of 
substrates from histones to non-histone proteins. Increasing evidence suggests that sirtuins also 
play roles in regulating autophagy. Sirt1 KO mouse embryonic fibroblasts have decreased 
autophagy in response to starvation, which is accompanied by increased acetylated Atg5, Atg7 
and LC3 proteins, although it remains unclear how increased acetylation of these proteins affects 
their functions on autophagy (Lee et al. 2008). In response to stress, cytosolic FoxO1 is dissociated 
from Sirt2 resulting in an increase of acetylated FoxO1. Acetylated FoxO1 then binds to Atg7 and 
promotes autophagy in some human cancer cells (Zhao et al. 2010). Adult-onset and long-term 
calorie restriction in mice increased Sirt1 expression in aged kidney and attenuated hypoxia-
associated mitochondrial and renal damage by enhancing Bcl2/adenovirus E1B 19 kDa-interacting 
protein 3 (Bnip3)-dependent autophagy. This increased autophagy was found to be regulated by 
Sirt1-mediated FoxO3 deacetylation resulting in increased expression of Bnip3 under hypoxia 
conditions (Kume et al. 2010). 
We recently demonstrated that acute ethanol treatment increased the expression of Atg genes 
in mouse liver and in primary cultured mouse and human hepatocytes, which was accompanied 
by increased hepatic nuclear accumulation of FoxO3 (Ni et al. 2013). Acute ethanol treatment 
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decreased the level of phosphorylated Akt, causing decreased FoxO3 phosphorylation at Ser253, 
which could account for increased nuclear FoxO3. As resveratrol could increase SIRT1 affinity 
for both NAD+ and the acetylated substrate through allosteric interaction (Howitz et al. 2003), 
activation of Sirt1 by resveratrol increased deacetylation of FoxO3 and thus enhanced ethanol-
induced expression of Atg genes. Moreover, we found that FoxO3 KO mice had decreased 
expression of Atg genes and had increased steatosis and liver injury compared to wild type mice 
after acute ethanol treatment (Ni et al. 2013). These findings indicate that FoxO3-mediated 
autophagy plays a protective role against alcohol-induced steatosis and liver injury. It has been 
suggested that ethanol consumption may inhibit Sirt1 via increased NADH/NAD+ ratio through 
its metabolism. This may lead to the inhibition of autophagy in the liver either through FoxO3-
dependent or independent mechanisms. However, ethanol consumption can also inhibit Akt 
phosphorylation, which can lead to increased nuclear retention of FoxO3 and ultimately increased 
expression of autophagy genes. Thus it is possible that Akt-mediated FoxO3 nuclear retention 
would be more important or dominant in regulating the expression of Atg genes than Sirt1-
mediated acetylation of FoxO3. Nevertheless, our results suggest that activation of Sirt1, such as 
by using resveratrol, can further enhance ethanol-induced FoxO3-mediated expression of Atg 
genes. More studies are definitely needed to determine whether other FoxO and sirtuin family 
proteins are also involved in autophagy in alcohol-induced liver injury. 
Interestingly, Nepal et al. found a link between AMPK/FoxO3 and autophagy when they 
studied the protective effect of globular adiponectin (gAcrp) on liver cells from ethanol-induced 
apoptosis (Nepal and Park 2013, Nepal et al. 2014). The fat-derived hormone adiponectin is 
significantly protective in ALD (Mandal et al. 2010). They showed that gAcrp restored ethanol-
induced suppression of autophagy genes including Atg5 and autophagosome formation, which was 
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accompanied by FoxO3 translocation. Silencing FoxO3 or its upstream regulator AMPK (Greer et 
al. 2007) abrogated the restoration, indicating the importance of FoxO3 and AMPK in autophagy 
in ethanol-induced injury possibly via modulating Atg5, in addition to the mechanisms mentioned 
previously. 
Methionine, SAM and Methylation 
Methionine is a sulfur-containing essential amino acid that is important in biogenesis of 
cysteine, carnitine, taurine, lecithin, phosphatidylcholine, and other phospholipids. Catalyzed by 
methionine adenosyltransferase, a liver specific enzyme, methionine is metabolized into S-
adenosylmethionine (SAM), which is a universal methyl donor. After transferring the methyl 
group, SAM becomes S-adenosylhomocysteine, which can be further converted to adenosine and 
homocysteine via S-adenosylhomocysteine hydrolase. Homocysteine is a source for generation of 
methionine through methionine synthase (MS) and glutathione through cystathionine b-synthase 
(Kharbanda 2009). Aberrant methionine metabolism has been well documented in ALD 
(Kharbanda 2009, Halsted and Medici 2012, Kharbanda 2013). Ethanol exposure inhibits MS 
activity resulting in decreased hepatic methionine levels (Kharbanda 2009). Cells activate a 
compensatory pathway in methionine metabolism by increasing betaine homocysteine 
methyltransferase activity, but this pathway is compromised under extended chronic alcohol 
exposure resulting in a general decrease of hepatic SAM and essential methylation reactions 
(Kharbanda 2013).  
Emerging evidence shows that post-translational modification of proteins with methylation 
may play important roles in regulating autophagy in at least three aspects: methylation of protein 
phosphatase 2A (PP2A) to negatively regulate autophagy through modulating mTOR (Sutter et al. 
2013), epigenetic regulation of autophagy gene transcription through the methyltransferase G9a 
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(Artal-Martinez de Narvajas et al. 2013), and arginine methylation in selective autophagy (Li et 
al. 2013). In a recent yeast study, it was found that methionine and SAM inhibited autophagy and 
promoted growth through the protein phosphatase methyltransferase 1 (Ppm1p), which increases 
PP2A methylation. Methylated PP2A promoted the dephosphorylation of natriuretic peptide 
receptor B (Npr2), a yeast phosphoprotein that negatively regulates TORC1, resulting in TORC1 
activation and autophagy inhibition (Sutter et al. 2013). However, whether methionine and SAM 
also inhibit autophagy in mammals through similar mechanisms remains to be studied. The H3K9 
methyltransferase G9a was also reported to inhibit autophagy by inducing an increase of 
dimethylated H3K9 (H3Kme2), which repressed the expression of several essential Atg genes 
including LC3B, WIPI1 and diabetes-and obesity-regulated (DOR). Upon autophagy induction, 
G9a leaves the promoter region of LC3B to release its repression on the expression of LC3B and 
other Atg genes to promote autophagy (Artal-Martinez de Narvajas et al. 2013). For selective 
autophagy, it is known that the autophagy receptor complex is important for mediating recognition 
of cargos (such as ubiquitinated mitochondria) and also binds with autophagy machinery proteins 
(such as LC3), which allows the cargo to be selectively removed (Kirkin et al. 2009, Ding et al. 
2010, Ding and Yin 2012, Manley et al. 2013). Phosphorylation of p62/SQSTM1 and Atg32, two 
important autophagy receptor proteins, has been shown to play important roles in selective removal 
of protein aggregates and mitochondria (Aoki et al. 2011, Matsumoto et al. 2011, Ichimura et al. 
2013). Optineurin, another autophagy receptor protein, is also phosphorylated by the protein 
kinase TBK1, which enhances its binding with LC3 resulting in selective autophagic clearance of 
cytosolic Salmonella enterica (Wild et al. 2011). In addition to phosphorylation, arginine 
methylation is another major type of protein post-translational modification and is catalyzed by 
protein arginine methyltransferases (PRMT). Interestingly, a recent study showed that mutations 
in C. elegans epg-11, a homologue of mammalian PRMT1, led to the defective removal of P 
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granule components phenolic glycolipid-1 (PGL-1) and PGL-3. Furthermore, mutating the 
methylated arginine residues on PGL-1 and PGL-3 resulted in impaired degradation of PGL-1 and 
PGL-3 (Li et al. 2013). These results indicate that modification of autophagic cargo proteins by 
arginine methylation may provide a regulatory mechanism for modulating autophagic degradation 
efficiency during selective autophagy. As discussed above, alcohol consumption impairs 
methionine metabolism and methylation reactions. It will be interesting to determine how these 
methylation changes would affect selective autophagy (such as mitophagy and lipophagy) and 
general autophagy in alcohol-induced liver disease in the future. The possible autophagic signaling 




Figure 1.4.1 The major molecular pathways and targets in alcohol-induced autophagy 
changes in hepatocytes. 
Ethanol modulates autophagy through multiple mechanisms: (1) Acute ethanol-induced 
autophagy requires ethanol metabolism and ROS production. ROS may activate autophagy by 
further suppressing mTOR. (2) Alcohol (ethanol) consumption inhibits methionine synthase 
(MS) resulting in decreased methionine and S-adenosylmethionine (SAM) levels. Methionine 
and SAM inhibit autophagy by activating mTORC1. Thus it is possible that ethanol-induced 
decreased methionine and SAM will inhibit mTORC1 resulting in autophagy activation 
although this has not been directly tested in the alcohol model (?). (3) Ethanol may also suppress 
Akt through the upregulation of PTEN and in turn inhibits mTORC1 to induce autophagy. (4) 
Ethanol-induced impaired AMPK and Akt may counteract each other on mTOR, and impaired 
Akt plays a dominant role toward the inhibition of mTOR. (5) Decreased Akt can also trigger 
autophagy through the activation of FoxO3 by promoting the dephosphorylation and nuclear 
retention of FoxO3. Increased NADH/NAD+ ratio through ethanol metabolism inhibits Sirt1 
activity resulting in increased acetylated FoxO3. Increased acetylated FoxO3 may decrease 
FoxO3-mediated expression of autophagy genes, which can be abolished by resveratrol that 
activates Sirt1. (6) Other AMPK-independent pathways remain to be determined in alcohol-
induced autophagy (?). (7) mTORC1 negatively regulates autophagy through direct 
phosphorylation (p) of ULK1 to inactivate ULK1 complex activity. ULK1 directly 
phosphorylates Beclin-1 and enhances VPS34 kinase activity to promote autophagy. AMPK 
positively regulates autophagy by suppressing mTORC1 activity through phosphorylation of 
TSC2 and Raptor and by promoting VPS34 kinase activity through phosphorylation of Beclin-
1. Activated VPS34 increases the production of phosphatidylinositol 3-phosphate, which 
promotes the biogenesis of autophagosomes although the activities of ULK1 and VPS34 after 
alcohol exposure still remain to be determined (?). 
Figure 1.4.1 
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1.4.3 Autophagy and Effect of Alcohol on Adipose Tissue 
Alcohol and Adipose Tissue Atrophy 
Increasing evidence has shown that the crosstalk between adipose tissue and liver is important 
in liver diseases, since adipose tissue is not only a lipid storage organ, but also a crucial endocrine 
organ secreting various adipokines (Schaffler et al. 2005, Marra and Bertolani 2009). Adiponectin 
(Xu et al. 2003), an adipokine exclusively secreted by adipose tissue, and agonist of PPAR-γ that 
is a receptor crucial in maintaining adipose expansion and adiposity (Shen et al. 2010, Sun et al. 
2012), could both improve lipid dysregulation and liver steatosis in mice.  
As discussed above, hepatic steatosis is the hallmark of early ALD pathogenesis. Several 
mechanisms could contribute to alcohol-induced steatosis, including increased lipid uptake and 
synthesis, decreased FA β-oxidation and VLDL secretion, and changed levels of humoral factors 
(Donohue 2007, Williams et al. 2014). Epidemiology studies have shown that habitual moderate 
and heavy drinkers have less body mass index, especially in males (Liangpunsakul et al. 2010). It 
is generally agreed that alcohol exposure leads to adipose tissue atrophy. In contrast, aberrant 
distribution of body fat and excessive accumulation of adipose tissue may exacerbate the 
development of ALD, as abdominal height is positively associated with fibrosis score in ALD 
patients (Naveau et al. 2013). Abundant evidence in animal experiments also indicates that long-
term alcohol intake induces adipose atrophy and disturbs lipid metabolism of adipose tissue, 
especially in WAT. Chronic alcohol feeding (4 weeks) in rats decreases white adipose tissue with 
increased TG degradation and increased lipolysis (Kang et al. 2007). Chronic alcohol exposure (8 
weeks) in mice reduces WAT, stimulates adipose tissue lipolysis, and inhibits adipose FA uptake, 
while supplement of rosiglitazone, the PPARγ agonist, normalizes the adipose gene expression 
and corrected lipid dyshomeostasis (Sun et al. 2012, Zhong et al. 2012). In addition to increased 
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lipolysis in adipocytes, chronic feeding with ethanol in rats showed decreased expressions of 
lipogenic enzymes including PPAR-γ and C/EBPα in epididymal WAT in ethanol group, 
suggesting that adipocyte tissue atrophy may also due to decreased lipogenesis. Notably, visceral 
WAT with higher ALDH metabolism was more susceptible to ethanol treatment than 
subcutaneous WAT, and aldehyde treatment in vitro and ex vivo was sufficient to suppress 
lipogenic enzymes (Zhang et al. 2015). This suggests that aldehyde, a product of alcohol 
metabolism, inhibits lipogenesis and contributes to the lipodystrophy in adipose tissue. 
Alcohol and Adipose Tissue Insulin Resistance, Inflammation and Lipolysis 
Insulin is a hormone produced by pancreatic beta cells. It mediates metabolism of 
carbohydrates, lipids, and proteins in multiple organs (liver, adipose tissue, skeletal muscle, etc.) 
to uptake, store, and utilize the glucose from food intake. In adipose tissue, it mainly increases the 
rate of glucose transport and glycolysis, decreases the rate of lipolysis, stimulates FA and TG 
synthesis and uptake, and increases the rate of protein synthesis (Dimitriadis et al. 2011). Insulin 
resistance refers to the genetic or acquired condition in which the body does not respond well to 
insulin. As a result, the pancreas produces more insulin while the blood glucose remains elevated. 
While insulin resistance often happens in metabolic disorders like type II diabetes and obesity, 
binge drinking has also been shown to impair whole body insulin sensitivity. Oral or 
intraperitoneal administration of alcohol in rats for three consecutive days had worse insulin 
response, reflected by higher blood glucose level and lipolysis rate in adipose tissue (Lindtner et 
al. 2013). Chronic alcohol consumption also impairs the insulin sensitivity of adipose tissue. 
Isolated epididymal and subcutaneous adipocytes from rats fed ethanol for 4 weeks had impaired 
glucose uptake, and had decreased response to insulin’s inhibition in β-adrenergic agonist-induced 
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glycerol release (Kang et al. 2007). Therefore, alcohol-induced adipocyte insulin resistance may 
also partially contribute to alcohol-induced adipose tissue atrophy by increasing lipolysis. 
Insulin resistance and obesity is often associated with macrophage infiltration in adipose 
tissue. Insulin resistance and type II diabetes can often be associated with a switch from M2 
(alternatively activated) macrophages secreting anti-inflammatory cytokines like Interlukin (IL)-
10 to M1 (classically activated) macrophages secreting pro-inflammatory cytokines like TNF-α, 
IL-6, and IL1-β (Lumeng et al. 2007), and increased presence of crown-like structures, i.e. 
macrophages surrounding dead adipocytes (Suganami and Ogawa 2010). Notably, chronic ethanol 
feeding for 4 weeks in rats also resulted in increased macrophages infiltration into epididymal 
adipose tissue with elevated mRNA of TNF-α, IL-6, CCL2, and decreased mRNA of adiponectin 
and retinol binding protein 4 (RBP4) (Kang et al. 2007). Dr. Nagy’s group has reported that 
chronic alcohol feeding (25 days) in mice induces apoptosis and inflammation in WAT in a 
CYP2E1/Bid/C1q-dependent manner (Sebastian et al. 2011). The same group also reported that 
chronic alcohol feeding (4 weeks) in rats suppresses adiponectin secretion and enhances markers 
of oxidative stress via CYP2E1 pathway (Tang et al. 2012). This suggests that ethanol metabolism 
and ethanol-induced adipocyte cell death promote inflammation in adipose tissue. 
It is well known that elevated intracellular cAMP concentration and enhanced catecholamine 
signaling stimulate the β2-adrenergic receptors on adipose tissue to increase lipolysis. Surprisingly, 
previous work from Dr. Nagy’s group has reported that chronic ethanol feeding suppressed beta-
adrenergic receptor-mediated lipolysis in adipocytes. They found that chronic ethanol feeding 
decreased beta-adrenergic receptor-stimulated protein kinase A activation that led to decreased 
phosphorylation of perilipin A and HSL. Moreover, chronic ethanol feeding increased 
phosphodiesterase 4 activity in adipocytes, resulting in decreased accumulation of cAMP (Kang 
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et al. 2007). In addition, epididymal adipocytes isolated from rats treated with chronic ethanol 
liquid diet exhibited similar basal lipolysis but decreased lipolysis in response to β-adrenergic 
agonist associated with increased phosphodiesterase 4 activity (Kang and Nagy 2006). However, 
chronic ethanol feeding markedly impaired insulin-mediated suppression of lipolysis in rats and 
in adipocytes isolated from epididymal and subcutaneous adipose tissue (Kang et al. 2007). These 
data suggest that alcohol induced adipose tissue atrophy is likely due to a suppression of the anti-
lipolytic effects of insulin in adipocytes but may not directly affect beta-adrenergic receptor.  
Notably, it is also reported that the change in lipoprotein lipase (LPL) activity, HSL activity 
and cAMP accumulation in WAT and BAT after ethanol exposure are very different depending 
on the dose and route of ethanol exposure, and tissue type (Shih and Taberner 1997). Moreover, a 
recent study also found that chronic feeding plus alcohol binge in mice increased adipose 
intracellular cAMP levels resulting in the activation of lipolytic enzymes and increased lipolysis, 
which can be reversed by supplying recombinant human fibroblast growth factor 21 (FGF21) 
(Zhao et al. 2015). Therefore it seems that the conditions of ethanol treatment may affect how 
ethanol induces adipocyte lipolysis. While the mechanisms for ethanol-induced adipocyte lipolysis 
are still controversial, it is consistent that alcohol consumption can lead to adipose tissue atrophy. 
Alcohol and Adipose Tissue Protein Metabolism and Autophagy Activity 
In addition to the known catecholamine and beta-adrenergic receptor-mediated lipolysis and 
insulin-mediated anti-lipolysis signaling in alcohol-induced adipocyte lipolysis, several other 
mechanisms are emerging that may also contribute to alcohol-induced adipose tissue homeostasis 
and lipolysis.  
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Chronic alcohol consumption is known to cause mass loss and dysregulated protein 
metabolism in skeletal muscle (Steiner and Lang 2015). Investigators found that the mechanisms 
include inhibited global protein synthesis (Preedy et al. 1997) and increased autophagy 
degradation (Thapaliya et al. 2014). Surprisingly, a recent study showed that mice with chronic 
ethanol feeding for 24 weeks had increased protein synthesis, which was associated with increased 
phosphorylation of mTOR substrate proteins and increased expression of Atg genes (Crowell et 
al. 2016). It is likely that increased mTOR-mediated protein synthesis may reflect an adaptive 
response of adipose tissue in response to alcohol-induced adipose tissue atrophy. While the authors 
found increased expression of Atg genes after alcohol exposure, no autophagy flux assay was 
performed in this study. It thus remains unclear whether autophagy is increased in adipocytes in 
this model. As discussed above, adipocyte-specific Atg5 or Atg7 KO mice have decreased adipose 
tissue mass, which is similar to chronic alcohol-induced adipose tissue atrophy. One would assume 
that chronic alcohol may also impair autophagy in adipocytes. To determine autophagic flux in 
vivo such as mouse adipose tissue is technically challenging, better animal models and autophagic 
flux markers need to be developed to tackle this important question in the future. 
 
1.4.4 Fat-liver Axis in Alcoholic Liver Disease 
Adipose tissue is an endocrine organ and secretes many bioactive substances, collectively 
called adipokines. So far, evidence suggests that more than 600 adipokines play specific roles in 
immune response, inflammation, glucose/lipid metabolism, insulin sensitivity, regulation of 
appetite and satiety, adipogenesis and bone morphogenesis, and other biological processes 
(Kloting and Bluher 2014). Excess adiposity or adipocyte dysfunction leads to dysregulation of 
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adipokines and nutritional metabolites, and thus affects other organs like liver (Girard and 
Lafontan 2008, Reilly et al. 2015) and skeletal muscle (Argiles et al. 2005). Correspondingly, the 
disorder in liver and skeletal muscle (Kim et al. 2013) can also affect the mass and functioning of 
adipose tissue. Below we discuss potential pathways of the crosstalk between adipose tissue and 
liver. 
Adiponectin 
Adiponectin or 30 kDa adipocyte complement-related protein (Acrp30) encoded by Adipoq is 
a protein hormone predominantly expressed in adipose tissue. Serving as an anti-diabetic 
adipocytokine, it regulates glucose level and FA breakdown. Metabolically it reduces body fat and 
improves insulin sensitivity (Berg et al. 2001). Moreover, adiponectin has anti-inflammatory 
effects such as blocking macrophage function (Yokota et al. 2000) and nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) signaling (Ouchi et al. 2000). Different forms of 
adiponectin supplementation have shown the potency of treating obesity, diabetes and insulin 
resistance (Haluzik 2005). Adiponectin has two receptors adiponectin receptor 1 (AdipoR1) and 
AdipoR2, and the latter is highly expressed in liver. Adiponectin is able to regulate liver steatosis, 
insulin resistance, inflammation and fibrosis by binding to these two receptors (Moschen et al. 
2012), all of these are important for the pathogenesis of ALD. Indeed, chronic alcohol feeding 
decreases circulating adiponectin in mice and rats (Chen et al. 2007), and supplementation of 
recombinant adiponectin alleviates alcohol-induced liver steatosis and injury (Xu et al. 2003). 
These data clearly support the notion that modulating adipose tissue function can affect the 
pathogenesis of ALD.  
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FGF21 
FGF21 is a member of FGF family. It is preferentially expressed in liver, and is inducible in 
adipose tissue (Owen et al. 2015). As an insulin-sensitizing metabolic regulator, it stimulates 
glucose uptake on adipocytes and also targets central nervous system (Markan et al. 2014). FGF21 
treatment corrects diet-induced obesity in mice, which suggests its therapeutic potency in obesity 
and fatty liver (Coskun et al. 2008). Moreover, Fgf21 transgenic mice are resistant to diet-induced 
obesity (Kharitonenkov et al. 2005). 
Increasing evidence indicates that FGF21 also regulates the pathogenesis of ALD at multiple 
levels. Fgf21 KO mice have increased sucrose consumption, whereas acute administration or 
overexpression of FGF21 suppresses the intake of both sugar and non-caloric sweeteners. FGF21 
regulates the neuron functions in the hypothalamus as a negative feedback loop in the liver-to-
brain hormonal axis, which reduces sweet-seeking behavior and meal size. Thus FGF21 acts 
centrally to suppress the intake of “sweets” by producing an endocrine satiety signal (von Holstein-
Rathlou et al. 2016). A recent study also showed that FGF21 administration reduces sweet and 
alcohol preference in mice and sweet preference in cynomolgus monkeys. In mice, the reduced 
preferences for sugar and alcohol require the FGF21 co-receptor β-Klotho in the central nervous 
system, which are also correlated with reductions in dopamine concentrations in the nucleus 
accumbens (Talukdar et al. 2016). A recent genome-wide association meta-analysis and 
replication study among a large population of individuals of European ancestry has identified β-
Klotho as a locus associated with alcohol consumption. In addition, brain-specific Klb KO mice 
increase alcohol preference, whereas FGF21 administration inhibits alcohol drinking by acting on 
the brain (Schumann et al. 2016). Therefore, in addition to regulating uptake of sweetness, the 
liver-brain endocrine axis may also play a critical role in the regulation of alcohol drinking 
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behavior. Since analogs of FGF21 are currently undergoing clinical evaluation for the treatment 
of obesity and type II diabetes, FGF21 may also be a potential pharmacologic target for reducing 
alcohol consumption. 
In addition, both hepatic and serum FGF21 levels increased after mice were either challenged 
with acute binge, chronic-plus-binge alcohol, or alcohol chronic feeding for 4 weeks. However, 
different alcohol models led to different outcomes for liver injury in Fgf21 KO mice (Zhao et al. 
2015, Liu et al. 2016, Desai et al. 2017). Chronic-plus-binge alcohol-induced liver injury and 
steatosis were attenuated in Fgf21 KO mice. In contrast, Fgf21 KO mice had more severe steatosis 
and liver injury compared with wild type mice when they were fed with chronic alcohol for 4 
weeks. The reasons for these apparent contradictory results were not clear but it suggests that 
different alcohol exposure model may be responsible for these contradictory findings. Notably, it 
is known that chronic-plus-binge model often leads to more hepatic neutrophil infiltration and 
inflammation, which are absent in the chronic alcohol feeding model. Whether lack of FGF21 
would differentially affect liver inflammation need to be further studied.  
As discussed above, chronic alcohol consumption reduces adipose tissue mass by increasing 
lipolysis. Interestingly, FGF21 deficiency also markedly reduces alcohol-induced WAT lipolysis, 
and administration of exogenous FGF21 exacerbates chronic alcohol-induced lipolysis. 
Mechanistically, the authors did not find any changes in the insulin levels but the levels of 
catecholamine decreased in Fgf21 KO mice (Zhao et al. 2015). Regardless of these controversial 
findings in chronic alcohol or chronic-plus-binge alcohol-treated Fgf21 KO mice, recombinant 
FGF21 treatment ameliorates liver injury and steatosis induced by alcohol (Zhu et al. 2014, Liu et 
al. 2016). Whether FGF21 also affects autophagy in adipose tissue and in turn affects the 
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pathogenesis of ALD remains to be an unanswered interesting question, which is currently under 
active investigation in our lab.  
 
1.4.5 Autophagy in Other Tissue Injuries Induced by Alcohol 
Heart 
Heart is mainly comprised of long-lived and post-mitotic cardiomyocytes. Increasing 
evidence indicates that autophagy plays an important role in maintaining the function and viability 
of cardiomyocytes by controlling the homeostasis of intracellular proteins, energy and organelles 
(Lavandero et al. 2013). Studies from genetic KO animal models, such as using the cardiomyocyte-
specific Atg5 KO mice, revealed that basal autophagy plays a vital housekeeping role in removing 
damaged organelles and proteins in cardiomyocytes to maintain their normal functions (Nakai et 
al. 2007). In contrast, both protective and detrimental roles of autophagy have been reported in 
“stressed” or “diseased” heart. For example, induction of autophagy is protective against ischemia-
induced heart injury, whereas autophagy could be detrimental in pressure overload-induced heart 
failure and during reperfusion (Matsui et al. 2007, Zhu et al. 2007).  
Low to moderate alcohol consumption is beneficial to patients with cardiovascular events 
(Costanzo et al. 2010). In contrast, heavy alcohol consumption impairs cardiac geometry and 
function (Ren and Wold 2008), and increases the incidence of sudden cardiac death and ventricular 
arrhythmias (Spies et al. 2001). Whether autophagy plays a protective or detrimental role in 
alcoholic heart disease is not fully understood. Jun Ren’s team has conducted a series of studies 
on ethanol-induced cardiac dysfunction with a focus on autophagy (Ge et al. 2011, Ge and Ren 
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2012, Guo et al. 2012, Guo and Ren 2012, Kandadi et al. 2013). In both binge (Ge et al. 2011) and 
chronic (Ge and Ren 2012) alcohol models, heart LC3-II levels were increased in an AMPK-
dependent manner. Furthermore results from this group’s studies tend to suggest that autophagy 
may contribute to alcohol-induced malfunction of cardiomyocytes. Acute ethanol treatment led to 
compromised heart functions with decreased fractional shortening, peak shortening and an 
intracellular Ca²⁺  rise in mouse cardiomyocytes. Acute ethanol exposure also increased LC3-II 
level, which was accompanied by increased phosphorylation of AMPK, Raptor, and decreased 
phosphorylation of mTOR and ULK1 in mouse cardiomyocytes. Interestingly, pharmacological 
or genetic inhibition of AMPK attenuated ethanol-induced autophagosome formation and 
cardiomyocyte apoptosis. Moreover, 3-methyladenine (3-MA) reversed ethanol-induced 
cardiomyocyte contractile defects (Guo and Ren 2012). Similar to acute ethanol treatment, chronic 
ethanol feeding also led to increased autophagosome formation in mouse cardiomyocytes with 
heart hypertrophy and cardiomyocyte contractile anomalies, and 3-MA treatment also ablated 
these ethanol-induced cardiomyocyte malfunction (Guo et al. 2012). Moreover, mice with cardiac-
specific overexpression of ADH, which metabolizes alcohol to acetaldehyde, were more 
susceptible to ethanol-induced autophagy changes and ethanol-induced damage of cardiomyocytes 
(Guo et al. 2012). In contrast, transgenic mice overexpressing ALDH2, which converts 
acetaldehyde to acetate during alcohol metabolism, blunted chronic alcohol-induced mTOR 
inhibition and increased LC3-II levels resulting in improved cardiac geometry and function in 
alcohol-treated mice (Ge and Ren 2012). These findings suggest that the ethanol metabolite 
acetaldehyde may account for ethanol-mediated autophagy changes and impaired cardiac 
functions.  
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 While these data generally suggest that either acute or chronic ethanol treatment may induce 
autophagy and contribute to ethanol-induced malfunction of cardiomyocytes, no clear autophagic 
flux data were shown in these studies. It is intriguing that acute ethanol treatment increased both 
LC3-II and p62/SQSTM1 in mouse cardiomyocytes (Guo and Ren 2012), although it is not clear 
whether the increased p62/SQSTM1 was due to decreased degradation or increased transcription. 
More studies, in particular the use of genetic autophagy-deficient animal models, are definitely 
needed to further clarify the autophagy status after alcohol exposure and the exact role of 
autophagy in alcohol-induced heart dysfunction. 
Brain 
It is well established that excessive ethanol intake results in regional brain damage and 
cognitive dysfunction (Harper and Matsumoto 2005, Harper 2009). Potential mechanisms that are 
responsible for alcohol-induced brain injury include higher sensitivity for excitotoxicity, impaired 
catabolism of homocysteine, reduced neurotrophic factors, failure to repair damaged DNA, 
acetaldehyde adduct formation and so on (Harper and Matsumoto 2005). It is generally thought 
that in the mature mammalian brain, autophagy is hard to detect even under nutrient deprivation 
conditions (Mizushima et al. 2004). This is probably due to the vital functions of brain that need 
to be protected from even systemic nutrient deprivation. However, neural cell-specific Atg5 KO 
mice have increased accumulation of cytoplasmic inclusion bodies in neurons and develop 
progressive deficits in motor function, suggesting that basal autophagy in the brain is important 
for preventing the accumulation of abnormal proteins to preserve neural function and protects 
against neurodegeneration (Hara et al. 2006). Moreover, both increased and impaired autophagy 
have also been observed in various acute brain injuries including those induced by alcohol (Smith 
et al. 2011, Chen et al. 2012). 
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Ethanol treatment increases autophagic flux in SH-SY5Y neuroblastoma cells and in the 
developing mouse brain through inhibition of mTOR. More importantly, induction of autophagy 
by rapamycin attenuates ethanol-induced ROS production and neuronal cell death in SH-SY5Y 
cells and in the mouse developing brain. In contrast, inhibition of autophagy either by wortmannin 
or shRNA knockdown of Beclin 1 exacerbates ethanol-induced neurotoxicity (Chen et al. 2012). 
Moreover, hypoxic preconditioning activates autophagy and protectes against ethanol-induced 
neurotoxicity, which is abolished when autophagy is inhibited by either BAF or wortmannin 
(Wang et al. 2013). These results suggest that autophagy protects against ethanol-induced neuronal 
injury. Fetal alcohol spectrum disorder (FASD) results from prenatal exposure to alcohol, which 
is the leading cause of mental retardation. Children with FASD often have neuropsychological and 
behavioral problems, and develop secondary disabilities including depression and anxiety 
disorder. Alimov et al. (Alimov et al. 2013) found that subcutaneous injection with ethanol 
induced neuroapoptosis in postnatal day 4 mice but not in postnatal day 12 mice. Interestingly, 
they further found that the expression of genes that regulate autophagy and the UPR was lower 
whereas the expression of pro-apoptotic genes was higher in postnatal day 4 mice than postnatal 
day 12 mice. These results imply that decreased autophagy activity may contribute to the 
vulnerability of the immature brain to alcohol exposure. However, a more recent study found that 
mice administrated 10% (v/v) ethanol for 4 months led to an accumulation of poly-ubiquitinated 
proteins in the mouse cerebral cortex likely due to an impaired ubiquitin-proteasome system and 
autophagy. Specifically, it was found that ethanol treatment increased mTOR activity and 
decreased expression of several Atg genes including Atg12, Atg5, p62/SQSTM1 and LC3. Ethanol 
treatment also increased brain inflammatory mediators such as IFN-γ. Interestingly, these ethanol-
induced changes were attenuated in Toll-like receptor 4 (Tlr4) KO mice, which were protected 
against chronic ethanol exposure-induced brain injury (Pla et al. 2014). These results suggest that 
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ethanol-induced impairment of the ubiquitin proteasome system and autophagy could be due to 
the activation of TLR4 by inflammatory mediators. In the future, more studies are needed to 
determine whether autophagy is activated or impaired after alcohol consumption using different 
animal models such as chronic-plus-binge model. Moreover, it will also be interesting to determine 
whether the metabolism of ethanol is required for ethanol-induced changes on autophagy in brain. 
Nevertheless, it seems that activation of autophagy is beneficial for alcohol-induced brain injury.  
Skeletal Muscle 
Skeletal muscles are composed of myofibers that control our body’s motion. Myofibers are 
composed of myofibrils that form highly organized units called sarcomeres, which contain 
repeating actin and myosin proteins. Approximately 40% of our body mass is from skeletal muscle, 
which also plays a critical role in regulating metabolism by providing amino acids through 
breaking down proteins and organelles to meet the energy needs of the body (Sandri 2010). Thus, 
it is not surprising that emerging evidence suggests that autophagy is important for controlling 
muscle mass. Modulating muscle autophagy also influences exercise, energy and lipid metabolism 
(Sandri 2010, Neel et al. 2013). Both beneficial and deleterious roles of autophagy in regulating 
muscle mass/wasting have been proposed. Activation of FoxO3 led to increased expression of Atg 
genes and activation of autophagy, which resulted in muscle atrophy (Mammucari et al. 2007, 
Zhao et al. 2007). MTMR14 is a lipid phosphatase that antagonizes Vps34 to dephosphorylate 
PI3-P to phosphatidylinositol (PI) and thus inhibits autophagy. Increased autophagy and muscle 
atrophy have been reported in MTMR14 knockdown zebrafish (Dowling JJ 2010; Vergne I 2009). 
Moreover, centronuclear myopathy was also found in humans that have MTMR14 mutations 
(Tosch et al. 2006). Paradoxically, muscle-specific Atg7 KO mice also developed myofiber 
degeneration and muscle atrophy accompanied with increased accumulation of protein aggregates, 
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abnormal mitochondria, sarcoplasmic reticulum distension, vacuolization, increased oxidative 
stress and apoptosis (Masiero and Sandri 2010). It is possible that autophagic degradation of 
proteins may lead to muscle atrophy whereas the muscle atrophy observed in the muscle 
autophagy-deficient mice is a maladaptive response due to the chronic loss of autophagy.  
In addition to regulating muscle mass, autophagy in muscle also regulates body glucose and 
lipid metabolism. For example, exercise induces autophagy in multiple organs involved in 
metabolic regulation including muscle, liver, pancreas and adipose tissue (He et al. 2012). Exercise 
increases Bcl-2 phosphorylation resulting in its dissociation from Beclin-1, which leads to the 
initiation of autophagy. Nonphosphorylatable mutation in Bcl-2 (Thr69Ala, Ser70Ala and 
Ser84Ala, Bcl2 AAA) knockin mice cause them to be defective in exercise- and starvation-induced 
autophagy, and they show decreased exercise endurance. These defects are due to impaired 
exercise-induced skeletal muscle glucose uptake because of a loss in glucose transporter 4 
(GLUT4) translocation (He et al. 2012, He et al. 2012). These findings suggest that autophagy 
may be beneficial for glucose homeostasis during exercise. Moreover, studies from muscle-
specific Atg7 KO mice also reveal that autophagy in muscle may regulate glucose and lipid 
homeostasis (Kim et al. 2013). Atg7 muscle-specific KO mice have decreased fat mass and are 
resistant to high fat diet-induced obesity and insulin resistance. Mechanistically, it has been 
suggested that loss of Atg7 may lead to accumulation of damaged mitochondria, which induces an 
Atf4-dependent production of FGF21 that increases FA oxidation and browning of WAT (Kim et 
al. 2013). Thus, these seemingly beneficial effects of loss of muscle autophagy on glucose and 
lipid metabolism could be a secondary adaptive response in response to organelle damage induced 
by the loss of autophagy. It is not clear how long these adaptive responses would last and whether 
maladaptive responses would develop after long term loss of muscle autophagy.  
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It is well known that chronic alcoholics have severe muscle loss and myopathy. Both in vivo 
and in vitro studies show that ethanol can inhibit skeletal muscle protein synthesis, which is likely 
mediated by increased expression of insulin-like growth factor binding protein-1 and myostatin [a 
transforming growth factor beta (TGF-β) superfamily member] resulting in the inhibition of 
mTOR and limitation of translational efficiency (Preedy et al. 1997, Lang et al. 1998, Lang et al. 
2004). Using skeletal muscle biopsies from alcoholic cirrhotics, gastrocnemius from ethanol and 
pair-fed mice, and ethanol-exposed murine myotubes, Thapaliya et al. provided evidence that 
autophagy contributes to alcohol-induced skeletal muscle loss (Thapaliya et al. 2014). Using a 
standard CT imaging technique, it was found that alcoholic cirrhotics had lower muscle mass than 
controls. Interestingly, proteasome components and activity were decreased in alcoholic biopsy 
samples, suggesting that decreased skeletal mass in alcoholic cirrhotics is less likely mediated by 
the proteasome. Indeed, they found that the expression of several essential Atg genes and 
autophagic flux were increased in alcoholic biopsy samples, ethanol-fed mice and ethanol treated 
C2C12 murine myotubes. Alcohol-induced autophagy was mediated by acetaldehyde, the 
metabolite of ethanol, rather than ethanol per se. More importantly, pharmacological or genetic 
inhibition of autophagy mitigated the proteolysis of myotubes and the reduction of muscle mass 
(Thapaliya et al. 2014). However, most of the results were obtained from short term alcohol 
exposure experiments. It is uncertain whether long-term blockage of autophagy would be 
beneficial for alcohol-induced muscle loss. More studies are needed to further dissect the 
underlying mechanisms by which autophagy regulates skeletal muscle mass in alcoholics. 
Pancreas 
Pancreas is a glandular organ that has both endocrine and exocrine functions in vertebrates. 
In response to fasting or feeding, pancreas secretes insulin or glucagon through its endocrine 
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system (islet β or α cells) to maintain blood glucose levels. Acute and chronic pancreatitis are 
characterized by intracellular activation of digestive enzymes, intracellular vacuolization, 
apoptosis, necrosis, edema and inflammation (Gaisano and Gorelick 2009, Gukovskaya and 
Gukovsky 2012). Chronic pancreatitis is also associated with a high risk for the development of 
pancreatic adenocarcinoma, for which no treatment is currently available (Chen and Ferec 2009, 
Gukovsky et al. 2013). 
Similar to the animal models for alcohol-induced liver injury, neither acute nor chronic 
administration of ethanol alone in rodents leads to pancreatitis. Alcohol-induced pancreatitis 
requires other additional factors such as a viral infection, a high fat diet or submaximal 
postprandial dose of CCK or cerulein or cholinergic stimulation (such as by carbachol). The 
precise mechanisms by which alcohol induces pancreatic damage remain vague. A series of 
elegant published work from Gaisano’s group showed that alcohol consumption may alter apical 
and basolateral exocytosis in pancreatic acinar cells (Cosen-Binker et al. 2007, Cosen-Binker et 
al. 2008). Mechanistically, it has been shown that alcohol induced protein kinase Cα, which 
phosphorylated Munc18c and displaced it from binding to basolateral plasma membrane syntaxin 
4 (Syn-4), which results in formation of the Syn4/ synaptosomal-associated protein 23 (SNAP23)/ 
vesicle-associated membrane protein 8 (VAMP8) fusion complex. The Syn4/SNAP23/VAMP8 
fusion complex then redirected the zymogen from apical exocytosis to basolateral exocytosis, 
which causes pancreatitis (Cosen-Binker et al. 2007, Lam et al. 2007, Cosen-Binker et al. 2008). 
Chronic ethanol feeding promotes a shift of acinar cell apoptosis to necrosis, but little is known 
about the mechanisms involved. In pancreas, ethanol is metabolized through both oxidative and 
non-oxidative pathways. Oxidative metabolism of ethanol is mediated by ADH in cytosol and 
ALDH2 in mitochondria, which generates acetaldehyde and acetate, respectively. Non-oxidative 
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metabolism converts ethanol to FAEE via fatty acyl responsive regulator (FarR) synthase. It has 
been shown that oxidative metabolism of ethanol causes mitochondrial failure by activating 
mitochondrial permeability transition, a key event in regulating cell death (Shalbueva et al. 2013). 
However, whether ethanol feeding would affect other necrotic proteins such as RIP3 in pancreas 
is not known although RIP3 is important in mediating ethanol feeding-induced liver injury in mice 
(Roychowdhury et al. 2013). In addition, as discussed above, ethanol feeding may also induce ER 
stress in acinar cells to trigger cell death (Lugea et al. 2011). Alcohol consumption can increase 
gut permeability, which causes bacterial translocation across the mucosal barrier, and leads to the 
elevation of lipopolysaccharide (LPS) levels. Alcohol-fed rats that were further treated with LPS 
had increased expression of TGF-β, which led to subsequent pancreatic fibrosis (Gu et al. 2013).  
Increasing evidence now supports the role of autophagy in both alcoholic and non-alcoholic 
pancreatitis, and it is generally thought that lysosomal/autophagic dysfunction can initiate 
pancreatitis. It has long been noted that there is an increased accumulation of large intracellular 
vacuoles in acinar cells in both experimental and human pancreatitis, and recent evidence indicates 
that the nature of these vacuoles is autophagic and lysosomal origin because these structures have 
double-membrane and are positive for LC3-II. In cerulein-induced acute alcoholic pancreatitis 
(AP), there was an increase in autophagosome numbers but autophagic flux was impaired due to 
lysosomal dysfunction (Gukovsky and Gukovskaya 2010). Decreased LAMP2 proteins and 
possible fusion of autophagosomes with lysosomes were also found in alcohol and LPS-induced 
AP (Fortunato et al. 2009). Moreover, Xbp1+/- mice fed with chronic ethanol had increased acinar 
cell death with loss of enzymogen granules. These mice also had increased LC3-II levels in acinar 
cells although autophagic flux assay was not performed in this study (Lugea et al. 2011). 
Mechanistically, autophagy may help remove zymogens through a selective process termed 
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zymophagy, which is regulated by the vacuole membrane protein (VMP1)-USP9x-p62/SQSTM1 
complex and attenuates intra-acinar trypsinogen activation. VMP1 interacts with Beclin-1 to 
promote the formation of autophagosomes, and it also interacts with the ubiquitin-protease USP9x 
to induce selective zymophagy, which prevents acinar cell death (Ropolo et al. 2007, Grasso et al. 
2011). In addition, results from Gukovskaya’s group suggest that inefficient autophagic 
degradation of zymogens due to defective lysosomal proteolytic activity may promote pancreatitis. 
They also proposed that an imbalance between cathepsin B (CatB) and cathepsin L (CatL) may 
result in decreased degradation of trypsin, which leads to pancreatitis (Mareninova et al. 2009, 
Gukovskaya and Gukovsky 2012). Moreover, mice with pancreas specific deletion of IKK-α, an 
essential component for NF-κB activation, develop spontaneous pancreatitis. Interestingly, 
decreased autophagic flux is found in the mouse pancreas with specific deletion of IKK-α. Similar 
to the autophagy-deficient liver, increased p62/SQSTM1 levels were also found in the IKK-α-
deficient pancreas, and further deletion of p62/SQSTM1 in the pancreas attenuated pancreatitis in 
pancreas-specific IKK-α-deficient mice (Li et al. 2013). Taken together, it seems that all of the 
above evidence supports that impaired autophagy may contribute to pancreatitis. Nevertheless, an 
early study using pancreas acinar cell-specific Atg5 KO mice showed decreased acinar cell 
vacuolization and pancreatitis after cerulein treatment, and the authors proposed that autophagy 
machinery may be required for the trypsinogen activation to induce pancreatitis (Hashimoto et al. 
2008). These results from acinar cell-specific Atg5 KO mice seem to be contradictory to the above 
other findings that suggest impaired autophagy promotes pancreatitis. However, Atg5 mainly 
regulates the upstream formation of autophagosomes, and it is possible that upstream autophagy 
(autophagosome biogenesis) and downstream of autophagy (autolysosome degradation) could 
play different roles in pancreatitis. Trypsinogen may use autophagosomes as vehicles for transport 
to lysosomes where trypsinogen is activated. Indeed, inhibition of the early phase of autophagy by 
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3-MA completely blocked trypsinogen activation (Gukovsky and Gukovskaya 2010). In contrast, 
impaired functions of downstream autolysosomes also led to trypsinogen activation and 
pancreatitis (Gukovskaya and Gukovsky 2012, Gukovsky et al. 2012). Therefore, it is possible 
that targeting different phases of autophagy may lead to different outcomes of pancreatitis. 
Suppression of early phase autophagosome formation and improvement of late autolysosome 
functions may attenuate pancreatitis, but future experiments are needed to test this hypothesis. 
1.4.6 Summary 
Recent rapid research progress has significantly enriched our knowledge on the molecular 
mechanisms regulating autophagy and its impact on human diseases. As outlined in this section, 
autophagy plays significant roles in alcohol consumption-induced multiple tissue/organ injuries 
including hepatic steatosis and liver injury, impaired heart function, brain damage, loss of muscle 
mass, and pancreatitis,. While autophagy has been generally considered as a cell survival 
mechanism, both beneficial and detrimental effects of autophagy have been reported in alcohol-
induced multiple tissue/organ injuries (Table 5). As a critical cellular mechanism sentinel for the 
homeostasis of proteins, energy, and organelles, autophagy may be beneficial for alcohol-induced 
liver injury through removing damaged mitochondria and lipid droplets, for brain injury through 
inhibiting ROS generation, and for AP through preventing zymogen activation. However, 
autophagy seems to be detrimental for alcohol-induced heart malfunction and muscle atrophy, 
although more studies are needed to further confirm these concepts due to limited research and 
lack of clear autophagic flux data in these two areas (Fig.1.4.2). Given the dynamic nature of 
autophagy and the chronic alcohol consumption process, we are still facing great challenges to 
monitor the autophagy status in vivo for chronic diseases induced by alcohol consumption. 
Similarly, it is also difficult to monitor the autophagy status in vivo after chronic modulation of 
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autophagy using either pharmacological autophagy inducers or inhibitors. More reliable in vivo 
autophagic flux assays are urgently needed to help further assess the therapeutic potential of 
pharmacological modulation of autophagy as a means to treat alcohol-induced tissue injuries. 
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Table 5 Summary of in vivo studies on autophagy in alcohol-induced tissue injury 





Liver Acute Activated Protective (Ding et al. 2010, Ni et al. 2013, Thomes et al. 2013) 
Impaired(*) Protective (Wu et al. 2012, Yang et al. 2014) (Zeng et al. 2012) 
Chronic Impaired Protective (Donohue 2009, Lin et al. 2013, Chao et al. 2018) 
Heart Acute Activated (*) Detrimental (Ge et al. 2011, Guo and Ren 2012, Kandadi et al. 2013) 
Chronic Activated (*) Detrimental (Ge and Ren 2012, Guo et al. 2012) 
Brain Acute Activated Protective (Chen et al. 2012, Alimov et al. 2013, Wang et al. 2013) 
Chronic Impaired Protective (Pla et al. 2014) 
Skeletal Muscle Chronic Activated Detrimental (Thapaliya et al. 2014) 
Pancreas Chronic Impaired Protective (Gukovsky et al. 2008, Fortunato et al. 2009) 





Figure 1.4.2 Differential roles of autophagy in alcohol-induced multi-tissue injury. 
Emerging evidence now indicates that alcohol consumption can either activate or impair 
autophagy as either a cellular adaptive/compensatory protective mechanism or as a detrimental 
factor contributing to alcohol-induced injury in various tissues/organs. In liver, it seems that 
alcohol metabolism through ADH and CYP2E1 is required for autophagy activation. Acute 
alcohol treatment also induces FoxO3-mediated autophagy. Autophagy seems to selectively 
remove damaged mitochondria and excess lipid droplets and in turn attenuate alcohol-induced 
steatosis and liver injury. In heart, alcohol may activate autophagy through activating AMPK and 
inactivating mTOR. Autophagy activation seems to contribute to alcohol-induced heart 
dysfunction. In muscle, metabolism of alcohol to acetaldehyde activates autophagy resulting in 
muscle loss. Whether alcohol-induced autophagy in muscle is mediated by mTOR is not clear. In 
brain, alcohol increases mTOR and impairs autophagy in the mouse cerebral cortex resulting in 
brain injury, which is TLR4-dependent. In pancreas, alcohol can induce ER stress and also 
decrease LAMP2 in the presence of endotoxin LPS, which leads to impaired autophagy resulting 
in pancreatitis. It is not known whether alcohol consumption would affect VMP1 and the ratio of 
CatB (cathepsin B) /CatL (cathepsin L), two important factors that regulate autophagy and 
pancreatitis, respectively. In adipose tissue, whether autophagy is involved in alcohol-induced 
atrophy, inflammation and insulin resistance is not known and will be determined by this study.  
Figure 1.4.2 
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1.5 Specific Aims 
1.5.1 Specific Aim 1: Investigate the phenotype of A-Atg5 KO mice under chronic-plus-binge 
alcohol treatment 
Autophagy is essential in adipose tissue development and physiological functions. We 
previously observed that chronic-plus-binge alcohol treatment and 32-day chronic alcohol 
treatment led to smaller adipose tissues along with mild liver injury and steatosis. I hypothesized 
that inhibiting adipose autophagy by specific Atg5 deletion would lead to adipose tissue dystrophy 
and dysfunction, and subsequently enable mice to be more resistant to alcohol-induced adipose 
atrophy and ALD. My goal in this aim was to characterize the phenotype of A-Atg5 KO mice and 
their response to chronic-plus-binge alcohol, especially the pathogenesis induced by alcohol in 
adipose tissue and liver. 
 
1.5.2 Specific Aim 2: Investigate the role of alcohol on adipose autophagy and the crosstalk 
between adipose tissue and liver in ALD 
 As discussed above, mice with autophagy deficiency in adipose tissue have decreased 
adipose mass. I hypothesized that alcohol would enhance adipose autophagy, and mice with 
chronic autophagy deficiency in adipose tissue would be more resistant to ALD. A possible 
mechanism is that chronic autophagy deficiency decreases adipose tissue mass (increased lipolysis 
and/or decreased lipogenesis) resulting in less FA uptake by the liver after alcohol treatment. My 
goal in this aim is to determine the effect of chronic-plus-binge alcohol on adipose autophagy, and 
if autophagy and/or other mechanisms contribute to ALD. 
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1.5.3 Specific Aim 3: Investigate the effect of alcohol and autophagy in preadipocyte 
differentiation 
Modulation of autophagy affects adipose tissue differentiation in vivo and in vitro, but the 
underlying mechanism is not fully understood. 3T3-L1 cells can be differentiated into adipocyte-
like cells under proper pharmacological induction. I hypothesized that alcohol would impair 3T3-
L1 preadipocyte differentiation partly via affecting autophagy. I aimed to utilize 3T3-L1 cell line 
and other in vitro models to determine the effect of alcohol on preadipocyte adipogenesis and 















CHAPTER 2. ADIPOSE AUTOPHAGY IN ALCOHOL-INDUCED ADIPOSE 




Autophagy is a highly conserved lysosomal degradative pathway essential in maintaining 
cellular homeostasis. Mice with autophagy-deficiency in adipose tissue presented impaired 
adipogenesis and altered metabolic parameters. Accumulating evidence indicates that chronic 
alcohol consumption also induces adipose tissue atrophy in both mice and human. However, 
whether alcohol-induced adipose atrophy is through autophagy, and more importantly whether 
autophagy-mediated adipose atrophy would contribute to alcohol-induced liver injury is unclear. 
In this study, we generated Adipose-specific Atg5 (A-Atg5) KO mice using Adipoq Cre and 
challenged these mice with chronic-plus-binge alcohol exposure. Mice given calorie-matched 
feeding and binge were used as controls, and A-Atg5 KO mice and matched Cre-negative (Cre-) 
littermates were compared. We found chronic-plus-binge alcohol inhibited Akt/mTOR signaling 
and enhanced autophagy degradation in epididymal adipose tissue. In addition, chronic-plus-binge 
alcohol decreased adipocyte/LD size in WT mice, but A-Atg5 KO mice were resistant to alcohol-
induced adipose atrophy and demonstrated increased browning in subcutaneous adipose tissue. 
Moreover, A-Atg5 KO mice were protected from alcohol-induced liver injury but not steatosis. 
Interestingly, A-Atg5 KO mice had higher circulating adiponectin at baseline, which may prime 
A-Atg5 KO mice to be resistant to alcohol-induced liver injury. In conclusion, constitutional 
autophagy deficiency in adipose tissue leads to reduced sensitivity to alcohol-induced adipose 




Alcohol-induced liver disease (ALD) is a severe health issue in U.S. and worldwide. Currently 
no successful treatments are available for ALD. As mentioned in chapter 1.2, autophagy is crucial 
in adipose tissue development and function. To specifically study role of autophagy in adipose 
tissue, I used Adipoq-Cre to delete Atg5 in mouse adipose tissue by crossing Adipoq-Cre mice 
with Atg5flox/flox (Atg5f/f) mice. Atg5 is an essential autophagy gene, which conjugates with Atg12 
and interacts with Atg16 to form a complex, serving as an E3 ubiquitin ligase that regulates the 
conjugation of LC3 with phosphatidylethanolamine (PE). This process is essential in 
autophagosome membrane elongation. Therefore, Atg5 deletion directly leads to autophagy 
deficiency. Preadipocytes with Atg5 knockdown and primary mouse embryonic fibroblasts 
(MEFs) from Atg5 KO mice show impaired adipogenesis (Singh et al. 2009). Atg5 KO embryos 
and neonatal pups have fewer subcutaneous fat cells (Baerga et al. 2009). These results suggest 
that Atg5 and possibly Atg5-mediated autophagy is required for normal adipogenesis process.  
Using A-Atg5 KO mice, I aimed to determine the effect of targeted autophagy deficiency on 




2.3 Materials and Methods 
Animals. Adipoq-Cre mice and Atg5f/f or Raptor f/f mice (backcrossed to C57BL/6J background) 
were crossbred to produce A-Atg5 KO mice and A-Raptor KO mice. The Cre- littermates were 
used as WT. Male and female (8- to 12-week-old) mice were used for ex vivo lipolysis assays, and 
only male mice (8- to 12-week-old) were used for chronic-and-binge ethanol model (Bertola et al. 
2013). In brief, mice were acclimated to the Lieber-DeCarli liquid diet (F1259SP, Bio-serv) for 5 
days, and then given ethanol (Decon)-containing (5%, v/v) liquid diet (F1258SP, Bio-serv) 
supplemented with maltose dextrin (Bio-serv) for 10 days. In the morning of the 15th day (i.e. day 
10 since ethanol feeding started), the mice were orally gavaged with ethanol (5 g/kg) (ETOH 
group). Mice administered with calorie- and volume- matched control liqud diet and maltose 
dextrin gavage were used as control (CTRL group). Body weight was monitored every two days. 
Food intake was recorded and matched daily after alcohol feeding started. Eight hours after 
gavage, mice were euthanized, and blood, epididymal WAT (eWAT), retroperitoneal WAT 
(rWAT), subcutaneous WAT (sWAT), interscapular BAT (iBAT) and liver tissues were collected 
for following assays. All procedures were approved by the Institutional Animal Care and Use 
Committee of the University of Kansas Medical Center. 
 
Protein Extraction and Western Blot. Fresh tissues were snap frozen in liquid nitrogen and then 
homogenized in ice-cold RIPA buffer [1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate (SDS)], followed by centrifugation at 12,000 g x 15 min at 4℃. The RIPA 
buffer was supplemented with protease inhibitor cocktail (BioTool). After centrifugation, the lipid 
layer was removed, supernatant was collected, and protein concentration was determined by BCA 
assay (Thermo). Samples were mixed with SDS loading buffer containing dithiothreitol (DTT) 
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and incubated at 95 °C for 10 min unless otherwise indicated. For non-heat-denaturing, non-
reducing conditions, samples were mixed with SDS loading buffer without DTT and were not 
heated. Thirty microgram of protein was separated by SDS polyacrylamide gel electrophoresis and 
transferred onto polyvinylidene difluoride (PVDF) membranes. Membranes were incubated in 
Ponceau S solution (Sigma) for 5 min if needed, and neutralized with 0.1M NaOH and washed in 
Millipore water before blocking. Membranes were blocked in 5% milk in Tris-buffered saline with 
0.1% Tween (TBST) at RT for 1 h, and then incubated with primary antibodies and secondary 
antibodies prepared in 5% milk in TBST. Signals were detected with SuperSignal West Pico 
Chemiluminescent Substrate (Thermal) and/or Immobilon Western HRP Substrate (Millipore). 
The following antibodies were used (Table 6). Anti-LC3 antibody was generated as previously 
described (Ding et al. 2010). Densitometry was analyzed with Image J software (National Institute 
of Health, USA). Band densities for the proteins of interest were normalized to β-actin unless 
otherwise indicated. 
Table 6 Summary of antibody information in Chapter II 
Antibody Company Catalog No. 
4E-BP1 Cell Signaling 9452 
phospho-4E-BP1 (Ser65) Cell Signaling 9451 
AKT  Cell Signaling 9272 
phospho-AKT (Ser473)(D9E) Cell Signaling 4060 
Atg5 Santa Cruz sc-33210 
β-actin Sigma A5441 
CYP2E1 Abcam Ab28146 
FGF21 Abcam ab64857 
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FoxO1 Cell Signaling 2880S 
phospho-FoxO1 (Ser256) Cell Signaling 9461S 
GAPDH Cell Signaling 2118 
GSK-3β Cell Signaling 5676 
phospho-GSK-3β Cell Signaling 5558 
OXPHOS cocktail Abcam ab110413 
p62/SQSTM1 Santa Cruz sc-28359 
UCP1 Abcam ab10983 
 
Protein Oxidation Detection. Protein oxidation/carbonylation was detected with Oxyblot kit 
(Millipore) following the manufacturer’s instructions. In brief, 5 μL of sample containing 20 μg 
of protein was denatured by 5 μL of 12% SDS. Samples were incubated with 10 μL of 1x 2-4-
dinitrophenyl hydrazine (DNPH) solution at RT for 15 min, and samples incubated with 1x 
Derivation-Control Solution was used as a negative control. Later, 7.5 μL of Neutralization 
Solution was added to stop the derivatization, and 1.5 μL 2-mercaptoethanol was added as 
reducing agent. Then the samples were loaded to SDS polyacrylamide gel for electrophoresis. The 
following steps were similar to common Western Blot procedures as mentioned above, except that 
the designated primary antibody (specific to the DNP moiety) and secondary antibody (goat anti-
rabbit IgG) in the kit were used. 
 
RNA Extraction and Real-time Polymerase Chain Reaction (PCR). For liver tissue, RNA was 
isolated with TRIzol Reagent (Invitrogen) following the manufacturer’s protocol. For adipose 
tissue, RNA was isolated with PureLink RNA Mini kit (Invitrogen) with or without TRIzol 
following the manufacturer’s protocol. RNA concentration and quality was determined by 
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spectrophotometer. One to three nanograms of RNA was used for cDNA synthesis with reverse 
transcription kit (Fermentas). mRNA levels of target genes were determined on an Applied 
Biosystems Prism 7900HT real-time PCR instrument (ABI, Foster City, CA) using Maxima SYBR 
green/rox qPCR reagents (Fermentas). 18s and 36b4 were used for normalization in liver samples 
and adipose tissue samples, respectively. The primer sequences were described in Table 7. 
Table 7 Summary of mouse primer sequences for qPCR 
Gene Forward Sequences (5' - 3') Reverse Sequences (5' - 3') 
18s GAGCGAAAGCATTTGCCAAG GGCATCGTTTATGGTCGGAA 
36b4 TAAAGACTGGAGACAAGGTG  GTGTACTCAGTCTCCACAGA  
Adipor1 CTTGACGATGCTGAGACCAA GCTGTGGGGAGCAGTAGAAG 
Adipor2 GCCCAGCTTAGAGACACCTG GCCTTCCCACACCTTACAAA 
Cidea CTCGGCTGTCTCAATGTCAA GGGATGGCTGCTCTTCTGTA 
Ccl2 ACATTCGGCGGTTGCTCTAG  ACATCCTGTATCCACACGGCAG  
Cox8b GAACCATGAAGCCAACGACT GCGAAGTTCACAGTGGTTCC 
Dio2 CAGTGTGGTGCACGTCTCCAATC TGAACCAAAGTTGACCACCAG 
F4/80 CTTTGGCTATGGGCTTCCAGTC GCAAGGAGGACAGAGTTTATCGTG 
Fgf21 CTGGGGGTCTACCAAGCATA CACCCAGGATTTGAATGACC 
Il-1b GCCCATCCTCTGTGACTCAT  AGGCCACAGGTATTTTGTCG  
Il-6 ACAAGTCGGAGGCTTAATTACACAT TTGCCATTGCACAACTCTTTTC 
Klb GATGAAGAATTTCCTAAACCAGGTT AACCAAACACGCGGATTTC 
Ly6g TGCGTTGCTCTGGAGATAGA CAGAGTAGTGGGGCAGATGG 
Prdm16 CAGCACGGTGAAGCCATTC GCGTGCATCCGCTTGTG 
Tnfa CGTCAGCCGATTTGCTATCT  CGGACTCCGCAAAGTCTAAG  
Ucp1 AGGCTTCCAGTACCATTAGGT CTGAGTGAGGCAAAGCTGATTT 
 
Histological Analysis. Fresh liver and fat tissues were fixed in 10% neutral-buffered formalin 
overnight, transferred to 70% ethanol for at least 24 h, embedded in paraffin wax, and cut into 5 
μm sections. For general morphology, slides were stained with hematoxyline and eosin (H&E). 
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For eWAT adipocyte area quantification, at least 3 fields of 10x images of each mice were 
analyzed in each group using Adipocyte Tools (Montpellier Ressources Imagerie) with Image J. 
For BAT LD quantification, at least 5 fields of 20x images of each mouse were analyzed using 
Image J.  
 
Immunohistochemistry Staining. Paraffin-embedded slides were rehydrated, quenched of 
endogenous peroxidase and blocked. Then the tissues were incubated with primary antibodies 
(1:1000) overnight at 4°C, and then incubated with biotinylated secondary antibodies. For 
neutrophil staining, slides were incubated anti-Ly6B2 antibodies (1:200) overnight at 4°C, and 
then incubated with biotinylated secondary antibody. For quantification, 10 fields of 20x images 
were randomly picked for each sample.  
 
Electron Microscopy. Fresh tissues and cells were fixed with 2.5% glutaraldehyde in 0.1 mol/L 
sodium cacodylate buffer (pH 7.4) followed by 1% OsO4. After dehydration, thin sections were 
stained with uranyl acetate and lead citrate. Digital images were captured using a JEM 1016CX 
electron microscope (JEOL, Peabody, MA).  
 
Liver Oil Red Staining. One gram of Oil Red O (Sigma) was dissolved in 200 ml isopropanol to 
make Oil Red O stock solution. The stock solution and Millipore water (v/v=6:4) was mixed well 
and filtered through 125mm filter paper (Whatman) to make working solution before use. Liver 
tissues were fixed with 4% paraformaldehyde (PFA) in PBS overnight at 4°C, transferred to 20% 
sucrose overnight at 4°C, and embedded in O.C.T. Compound (Fisher). For microscopy, tissues 
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were cut into 5 μm slides using a cryostat. The cryostat sections were dried at 37°C and washed 
twice with PBS, incubated in 60% 2-propanol for 1 min, dried again at 37 °C, and incubated with 
Oil Red O working solution for 10-15 min at RT. Then the slides were washed with 60% 2-
propanol for 2-5 min, one time and with PBS, three times. After counterstaing with hematoxylin 
for 5 sec, the slides were washed with RO water for at least 3 min and mounted with glycerol in 
PBS (v/v=5:1). Images were captured within the same day. 
 
Liver TG and Cholesterol Analysis. Liver TG and cholesterol levels were determined as 
previously reported (Buettner et al. 2000). Frozen liver tissue (20 to 50 mg) was ground in liquid 
nitrogen using a mortar and a pestle. Then the homogenate was incubated with 1 mL of 
chloroform/methanol (v/v=2:1) with vigorous shaking for 1 h at room temperature (RT). Then 200 
μL of Millipore water was added into the mix and centrifuged at 3000 g for 5 min. The lower lipid 
phase was collected and dried in fume hood overnight, and the pellet was dissolved in 60 μL of 
tert-butanol and 40 μL of Triton X-114/methanol (v/v=2:1) mix. Liver TG and cholesterol levels 
were measured with colorimetric assay kits following the manufacturer’s instructions (Pointe 
Scientific) and normalized to tissue weight. The tert-butanol and Triton X-114/methanol mixture 
was used as a blank control. 
 
Serum Biochemical Analysis. Blood samples were collected via cardiac puncture, sat on ice for 
at least 30 min, centrifuged at 3,000 min at 4°C for 10 min, and the supernatant was collected as 
serum samples. Serum alanine aminotransferase (ALT) and aspartase aminotransferase (AST) 
levels were measured with fluorometric assay kits (Pointe Scientific). Serum TG and cholesterol 
levels were measured with colorimetric assay kits (Pointe Scientific). Serum FFA level was 
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measured with a fluorometric assay kit (BioVision). Serum free glycerol level was measured with 
a colorimetric assay kit (Sigma-Aldrich). Serum β-hydroxybutyrate (β-HB) level was measured 
with a colorimetric assay kit (BioVision). Millipore water was used as a blank control. All assays 
were performed following the manufacturer’s instructions on a spectrometer unless otherwise 
indicated. 
 
Enzyme-linked Immunosorbent Assay (ELISA). Serum samples were collected as described 
above. 2.5 μL of serum was used to measure the adiponectin level with a commercial kit 
(Millipore) following the manufacturer’s protocol. 10 μL of serum was used to measure the FGF-
21 level with a commercial kit (R&D) following the manufacturer’s protocol. 
 
Ex Vivo Lipolysis Assay. Ex vivo lipolysis assay was performed as previously described (Zhang 
et al. 2015). In brief, after mice were euthanized, eWAT and sWAT tissues were collected, cut 
into smaller pieces, and weighed (around 50mg per piece). Each piece was placed in 12-well plate 
and incubated in Dulbecco's Modified Eagle Medium (DMEM) with or without isoproterenol on 
an orbital shaker for 1 h. The free glycerol released in medium was measured and normalized to 
tissue weight. 
 
Statistical Analysis. Experimental data were subjected to Student’s t test or One-way ANOVA 




2.4.1 Chronic-plus-binge Alcohol Treatment Leads to Adipose Atrophy Associated with 
Inhibited Akt/mTOR Signaling and Increased Autophagy 
Eight-week alcohol feeding in mice decreased fat tissue size and weight (Sun et al. 2012, 
Zhong et al. 2012). The effect of chronic-plus-binge alcohol exposure on adipose tissue was hardly 
studied. We confirmed that the 32-day alcohol feeding significantly decreased the weight of eWAT, 
rWAT and iBAT (Fig.2.4.1A), and decreased the LD size of iBAT (Fig.2.4.1B). Moreover, we 
found that the chronic-plus-binge treatment significantly decreased adipose tissue weight and the 
LD size of iBAT (Fig.2.4.1A, B) in C57BL/6J WT mice, suggesting that chronic alcohol and 
chronic-plus-binge treatment leads to adipose atrophy. 
Adipose-specific mTOR/Raptor KO mice develop lipodystrophy (Lee et al. 2016, Shan et al. 
2016). In our hands, we confirmed that mice with adipose-specific Raptor deletion had 
significantly smaller white and brown adipose tissues, a phenotype similar to alcohol-treated mice 
(Fig.2.4.2). Thus we sought to determine if alcohol exposure leads to adipose atrophy involving 
mTOR inhibition. We found that in eWAT after chronic-plus-binge treatment, both the levels of 
upstream phosphorylated protein kinase B (Akt/PKB) and total Akt proteins decreased 
(Fig.2.4.1C). Moreover, the levels of total and phosphorylated levels of glycogen synthase kinase-
3 beta (GSK3β) and FoxO1, two downstream signaling nodes of Akt, also decreased after chronic-
plus-binge alcohol. Both the total and phosphorylated levels of 4EBP1, the target substrate of 
mTOR, also decreased after chronic-plus-binge alcohol. These data suggest that chronic-plus-
binge alcohol treatment inhibits Akt/mTOR signaling in mouse adipose tissue.  
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mTOR inhibition is a common trigger of autophagy activation. Previous studies reported that 
adipose-specific Atg5 or Atg7 KO mice had smaller adipose tissue (Baerga et al. 2009, Zhang et 
al. 2009). Therefore, we thought to answer if alcohol exposure leads to adipose atrophy involving 
the autophagy pathway. Interestingly we found that in eWAT after chronic-plus-binge treatment, 
the levels of both LC3-II and p62 and decreased, (Fig.2.4.1D, E). p62 is a well-known autophagy 
substrate protein that is often degraded by increased autophagy. LC3-II decorateds the outer and 
inner membrane of autophagosomes, but LC3-II is also degraded by autolysosomes. Therefore, it 
is likely that decreased p62 and LC3-II in adipose tissue after chronic-plus-binge alcohol is due to 








Figure 2.4.1 Alcohol induced adipose atrophy is associated with inhibited mTOR and 
increased autophagy in epididymal white adipose tissue. 
C57BL/6J WT mice were treated with either 32-day chronic alcohol feeding, and fat tissues 
were collected on the last day; or 10-day chronic-plus-binge alcohol treatment, and fat tissues 
were collected 8 h after binge. (A) Adipose tissue weight quantification. (B) representative 
H&E staining of iBAT tissues of C57BL/6J WT mice after alcohol treatment (32-day: n=4 mice 
per group; chronic-plus-binge: n=4-8 mice per group). Magnification=200x. (C)(D) 
Representative western blot of eWAT and liver of C57BL/6J WT mice with chronic-plus-binge 
treatment. β-actin and GAPDH was used as loading control. (E) Densitometry of (D) (n=5 mice 
per group). CTRL: control treatment group; ETOH: ethanol treatment group. Data shown are 
mean±SEM. *p<0.05(CTRL vs ETOH) by Student’s t test. 




Figure 2.4.2 Adipose-Raptor deficient mice developed adipocyte atrophy.  
Fat samples were collected from Raptorf/f, Adipoq-Cre- and -Cre+ mice (A) Representative 
epididymal (eWAT), subcutaneous (sWAT), retroperitoneal (rWAT) white adipose tissue and 
interscapular brown adipose tissue (iBAT). (B) Quantification of adipose tissue weight (n=3-
7 mice per group). Data shown are mean±SEM. *p<0.05 (Cre- vs Cre+) by Student’s t test. 
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2.4.2 A-Atg5 KO Mice Are Less Sensitive to Chronic-plus-binge Alcohol-induced Adipose 
Atrophy 
To study adipose autophagy, we crossed Adipoq-Cre mice with Atg5f/f mice in which LoxP 
sites flank exon 3 of Atg5 (Fig.2.4.3A). We first examined if Atg5 deletion was specific and potent 
in adipose tissues. Atg5-Atg12-Atg16 complex functions as an E3 ligase essential for the lipidation 
of LC3. When Atg5 is absent, LC3-II formation is interrupted, so the autophagy process is halted 
and the adaptor protein p62 accumulates. In A-Atg5 KO mouse, the level of Atg5-Atg12 conjugate 
decreased in eWAT, sWAT and iBAT along with increased p62 and LC3-I (Fig.2.4.3B), 
suggesting deficient autophagy in A-Atg5 KO mice. Noticeably, the basal level of autophagy 
proteins and even internal controls were very different among different adipose tissues. We also 
examined liver and skeletal muscle since they are crucial in nutrient metabolism and tightly 
associated with adipose tissues. Atg5-Atg12, p62 and LC3 were not affected in liver or skeletal 






Figure 2.4.3 Generation and validation of adipose tissue-specific Atg5 knockout mice.  
(A) Targeting strategy for conditional Atg5 deletion. (B) Skeletal muscle, liver, eWAT, sWAT 
and iBAT tissues were collected from Atg5f/f, Adipoq-Cre- and -Cre+ mice, and protein was 
extracted and subjected to western blot. Liver protein lysate from Atg5 F/F, Albumin-Cre+ mouse 
was used as negative control. GAPDH and β-actin were used as internal control. 
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To our surprise, the ratio of various adipose tissues vs body weight in A-Atg5 KO mice had 
no significant difference when compared with WT mice (Fig.2.4.4A). In response to chronic-plus-
binge alcohol, WT mice had slightly reduced WAT mass (by 10-20%) and significantly reduced 
iBAT mass, while the iBAT mass of A-Atg5 KO mice was significantly higher than WT mice. 
The size of adipocyte/LD in eWAT and iBAT decreased after alcohol treatment in WT mice, but 
it remained unchanged in A-Atg5 KO mice (Fig.2.4.4B). In WT mice, 25% of eWAT adipocytes 
had an area of 400-1600 pixel/100x field, while in KO mice only about 40% of eWAT adipocytes 
were in the 400-1600 range and fewer adipocytes were in the larger area range (Fig.2.4.4C). In 
addition, alcohol decreased LD size per field by ~40% and per cell by ~50% in iBAT in WT but 
not in A-Atg5 KO mice (Fig.2.4.4D). In our hands, mouse body weight usually drops a little in the 
first few days since alcohol feeding starts (counted as Day 1) and gradually restores once the mice 
are acclimated to ethanol-containing liquid diet. The body weights on Day 1 and the last day of 
feeding (Day 10) were not significantly different between WT and KO mice (Fig.2.4.5A). The 
average food intake from Day1 to Day 10 was also not changed in KO mice (Fig.2.4.5B). Taken 
together, A-Atg5 KO mice presented resistance to alcohol-induced adipose atrophy especially in 








Figure 2.4.4 (Cont.) 
Figure 2.4.4 Adipose-Atg5 deficient mice were partially resistant to alcohol-induced 
adipocyte atrophy. 
WT and A-Atg5 KO and mice were treated with chronic-plus-binge alcohol, and fat samples were 
collected 8h after binge. (A) Quantification of epididymal (eWAT), subcutaneous (sWAT), 
retroperitoneal (rWAT) white adipose tissue and interscapular brown adipose tissue (iBAT) 
weights (n=5-21 mice per group). (B) Representative H&E staining of eWAT and iBAT tissues 
(magnification=20x). (C) Distribution of eWAT adipocyte area in H&E staining (n=3-6 mice per 
group). (D)Quantification of iBAT LD area in H&E staining (n=4-8 mice per group). Data shown 




Figure 2.4.5 Adipose-Atg5 deficient mice had similar body weight and food intake to WT 
mice.  
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and body weight and 
food intake were recorded. (A) The average body weight on Day 1 (since alcohol feeding started) 
and Day 10 (n=8-12 mice per group). (B) The average food intake (n=8-12 mice per group). 
Data shown are mean±SEM.  
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2.4.3 A-Atg5 KO Mice Have Increased sWAT Browning 
Autophagy-mediated degradation of mitochondria is a hallmark feature of the transition of 
browning adipocytes to white adipocytes (Altshuler-Keylin et al. 2016). Therefore, lack of 
autophagic removal of mitochondria may favor the browning of white adipocytes. We found 
depots of adipocytes with multilocular LDs around lymph nodes in sWAT of A-Atg5 KO mice, 
which was further increased after chronic-plus-binge alcohol treatment. Multilocular LDs were 
rarely seen in WT mice (Fig.2.4.6A). In EM studies, there were increased mitochondria numbers 
in sWAT adipocytes of A-Atg5 KO mice after alcohol treatment (Fig.2.4.6B). Alcohol treatment 
increased the levels of UCP1 protein. The basal levels of UCP1 protein and mitochondria oxidative 
phosphorylation proteins markedly increased in sWAT of A-Atg5 KO mice compared with the 
matched wild-type mice (Fig.2.4.6C). However, the gene expression of genes that thought to be 
specially expressed in brown/beige adipocytes including Ucp1, Prdm16, Cox8b, Dio2, and Cidea, 




(See figure legend on next page.) 
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Figure 2.4.6 Adipose-specific Atg5 deficient mice had increased sWAT browning.  
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and sWAT samples 
were collected 8h after binge. (A) Representative H&E staining of sWAT. (B) Representative 
EM image of sWAT. (C) Representative western blot image. sWAT was subjected to protein 
extraction and western blot. GAPDH was used as internal control. (D) sWAT was subjected to 
mRNA extraction and qPCR (n=4-5 mice per group). 
Figure 2.4.6 (Cont.) 
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2.4.4 A-Atg5 KO Mice Are Protected from Alcohol-induced Liver Injury but Not Steatosis 
We next examined alcohol-induced liver injury and steatosis in A-Atg5 KO mice. In WT mice, 
chronic-plus-binge alcohol treatment resulted in liver macrosteatosis and microsteatosis, i.e. 
visualization of big and small LDs, in H&E staining (Fig.2.4.7A). This observation was supported 
by increased Oil Red O staining of liver tissue (Fig.2.4.7B), with significantly increased liver/body 
weight ratio (Fig.2.4.7C) and liver TG (Fig.2.4.7D) in alcohol-treated mice compared with control 
mice. Liver cholesterol was slightly increased after alcohol (Fig.2.4.7D). These data suggest that 
chronic-plus-binge alcohol induces hepatic steatosis in mice. A-Atg5 KO mice had similar 
morphology of H&E and Oil Red O staining in response to alcohol. In addition, the changes of 
liver weight, levels of hepatic TG as well as cholesterol were also similar in A-Atg5 KO mice 
compared with WT mice. These data suggest that A-Atg5 KO mice do not affect alcohol-induced 
steatosis.  
ALT and AST are enzymes usually found in liver but released into blood when hepatocytes 
are damaged. AST may also come from other tissues like heart and muscle. Though the level of 
serum ALT and AST can be affected by various mechanisms, they are two common markers 
indicating liver injury. In WT mice, chronic-plus-binge treatment led to elevated serum levels of 
ALT and AST significantly compared with control mice (Fig.2.4.7E) but no obvious cell death in 
liver H&E staining were observed (Fig.2.4.7F). In A-Atg5 KO mice, the serum levels of ALT and 
AST were significantly lower than WT mice after chronic-plus-binge alcohol. This suggests that 




Figure 2.4.7 Adipose-Atg5 deficient mice were protected from alcohol-induced liver injury 
but not steatosis.  
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and serum and liver 
samples were collected 8h after binge. (A) Representative images of liver H&E staining 
(magnification=20x). (B) Representative images of liver Oil Red O staining (magnification=20x). 
(C) Quantification of liver weight (n=8-15 mice per group). (D) Liver tissue was subjected to lipid 
extraction, and TG and cholesterol levels were measured (n=8-12 mice per group). (E) Serum ALT 
levels were measured (n=8-20 mice per group). (F) Serum AST levels were measured (n=6-16 
mice per group). Data shown are mean±SEM. *p<0.05 (CTRL vs ETOH), #p<0.05 (Cre- vs Cre+) 
by One-way ANOVA.  
Figure 2.4.7 
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2.4.5 Protection against Alcohol-induced Liver Injury in A-Atg5 KO Mice Is Independent of 
Liver CYP2E1 Expression, ROS Generation, and Neutrophil Infiltration 
In liver, alcohol metabolism is mainly catalyzed by ADH in the cytosol, CYP2E1 in 
microsomes and catalase in peroxisomes (Cederbaum 2012). The metabolism via CYP2E1 is 
largely responsible for ethanol-induced oxidative stress, and may contribute to ethanol-induced 
cell injury (Bardag-Gorce et al. 2000, Bradford et al. 2005, Lu and Cederbaum 2008). We asked 
if the liver protection in A-Atg5 KO mice was due to altered CYP2E1 metabolism and ROS 
production. We found that, alcohol treatment induced CYP2E1 proteins almost to the same levels 
in A-Atg5 KO and WT mice (Fig.2.4.8A, B).  
The production of ROS promotes protein carbonylation, i.e. carbon monoxide introduced into 
protein side chains. The abundance of protein carbonyl groups like aldehyde and ketone is 
considered as a biomarker of oxidative damage (Fedorova et al. 2014). Carbonyl groups react with 
DNPH and generate DNP-derived proteins which can be detected via western blot using specific 
antibodies for DNP. We found alcohol treatment significantly increased carbonylation almost to 
the same levels in that in both WT and A-Atg5 KO mice (Fig.2.4.8C, D). Taken together, ethanol-
induced CYP2E1 and ROS generation was not different in A-Atg5 KO mice compared with WT 





Figure 2.4.8 Adipose-Atg5 deficient mice had similar liver CYP2E1 and ROS generation 
after chronic-plus-binge alcohol.  
(A) WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and liver samples 
were collected 8h after binge. Liver total protein was extracted and subjected to western blot. β-
actin was used as internal control. (B) Densitometry of (A). (C) Liver total protein was subjected 
to western blot detecting carbonylation. NC: Negative control. (D) Densitometry of (C). Data 
shown are mean±SEM. *p<0.05 (CTRL vs ETOH) by One-way ANOVA. 
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Chronic alcohol-induced liver injury is associated with increased pro-inflammatory cytokines 
and chemokines and infiltration of inflammatory cells. We found in WT mice, chronic-plus-binge 
alcohol slightly increased neutrophil infiltration in the liver (Fig.2.4.9 A, B). Consistently, alcohol 
treatment significantly increased liver Ly6g mRNA level, a marker of neutrophils, monocytes and 
granulocytes (Fig.2.4.9 C). In A-Atg5 KO mice, we found that the neutrophil number seen in each 
field and the Ly6g mRNA level was similar to WT mice before and after alcohol. There was no 
significant induction of proinflammatory cytokines such as Tnfa, Il-1b or Il-6, or macrophage 
marker F4/80 in liver after alcohol treatment. However, we found that alcohol treatment increased 
expression of Ccl2, a chemokine regulating recruitment of monocytes and macrophages, to almost 
12 fold compared with control mice (Fig.2.4.9 C). In A-Atg5 KO mice, the mRNA levels of Tnfa, 
Il-1b, Il-6 or F4/80 were either similar to or higher than those in WT mice. However, the level of 
Ccl2 mRNA was significantly lower in A-Atg5 KO mice than in WT mice after alcohol treatment. 
These data suggest that chronic-plus-binge alcohol may only lead to mild hepatic inflammation. 




Figure 2.4.9 Adipose-Atg5 deficient mice were protected from chronic-plus-binge alcohol-
induced liver injury independent of liver neutrophil infiltration.  
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and liver samples were 
collected 8h after binge. (A) Representative images of liver Ly6B2 immunochemistry staining 
(magnification=10x). Arrow indicates neutrophils. (B) Quantification of (A) (n=4-6 mice per 
group). (C) Liver was subjected to mRNA extraction and qPCR (n=4-5 mice per group). Data 
shown are mean±SEM. *p<0.05 (CTRL vs ETOH) by One-way ANOVA.  
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2.4.6 A-Atg5 KO Mice Have Similar Levels of Serum Lipids but Increased Basal Levels of 
Adiponectin and FGF21. 
Lipolysis in adipose tissue is a stepwise breaking down of TG into FFAs and free glycerol 
mediated by lipases. Chronic alcohol exposure increases adipose lipolysis releasing FFAs and 
contributes to liver steatosis (Zhong et al. 2012). We determined whether chronic-plus-binge 
alcohol increased circulating lipids that may exacerbate liver steatosis (Fig.2.4.10A). In WT mice, 
alcohol treatment significantly increased serum FFA from 0.012 mM to 0.297 mM suggesting 
increased lipolysis (Fig.2.4.10B-D). Serum TG, cholesterol and free glycerol levels were not 
increased by alcohol. In A-Atg5 KO mice, the change in serum TG, cholesterol, FFA levels was 
similar to WT mice. The serum free glycerol level of KO mice was slightly lower than WT mice 
at the basal level. However, after alcohol treatment, the serum levels of glycerol increased to 
almost the same levels with WT mice. Taken together, these data suggest that A-Atg5 KO mice 
have similar serum lipids to WT mice after alcohol treatment. 
FFAs released from adipocytes are taken up by hepatocytes and broken down into acetyl-
CoAs in mitochondria for β-oxidation. Usually, acetyl-CoAs enter tricarboxylic cycle and generate 
ATPs. Under certain conditions like starvation, diabetic ketoacidosis and alcoholic ketoacidosis, 
acetyl-CoA metabolism shifts towards ketone body formation and generate metabolites including 
β-HB. Thus β-HB concentration partly reflects liver FA metabolism via β-oxidation. A recent 
study reported that β-HB protected chronic-plus-binge alcohol-induced liver injury via 
Hydroxycarboxylic acid receptor 2 (Hcar2) on liver macrophages (Newman and Verdin 2014, 
Chen et al. 2018). We found in WT mice, serum β-HB level was significantly increased to 3-fold 
after chronic-plus-binge alcohol treatment (Fig.2.4.10E). In A-Atg5 KO mice, serum β-HB had 
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higher basal level (50% increase), and was similar to WT mice after alcohol. This suggests that 
ketogenesis following FA β-oxidation in liver was similar in A-Atg5 KO and WT mice. 
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Figure 2.4.10 Adipose-Atg5 deficient mice had no change in serum lipids. 
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and serum samples 
were collected 8h after binge. (A) Serum TG and (B) cholesterol levels were measured (n=7-
12 mice per group). (C) Serum FFA level was measured (n=7-11 mice per group). (D) Serum 
free glycerol level was measured (n=8-14 mice per group). (E) Serum β-hydroxybutyrate (β-
HB) level was measured (n=7-12 mice per group). Data shown are mean±SEM, *p<0.05 (CTRL 
vs ETOH) by One-way ANOVA.  
Figure 2.4.10 
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Adiponectin is secreted by adipose tissue and targets liver via receptors AdipoR1 and 
AdipoR2. Adiponectin regulates lipid and glucose metabolism and plays a protective role in 
various metabolic scenarios, and its response to alcohol exposure is still debatable. We found in 
WT mice the circulating adiponectin detected by ELISA increased from 9.97 ng/mL to 16.36 
ng/mL in response to chronic-plus-binge alcohol (Fig.2.4.11A). Interestingly in A-Atg5 KO mice, 
the serum adiponectin was as high as 17.39 ng/mL at the basal level, and slightly decreased to 
15.48 ng/mL after alcohol. Circulating adiponectin exists in different multimerized forms, and 
these complexes have different biochemical characteristics and activate different signal 
transduction pathways. Therefore, we checked multimerization of serum adiponectin protein in a 
non-heat denaturing and non-reducing condition (Waki et al. 2003). Consistently, we found 
increased high-molecular-weight (HMW) adiponectin in serum of WT mice after alcohol and in 
KO mice with or without alcohol treatment (Fig.2.4.11B). The mRNA level of liver Adipor1 was 
increased 1-fold in response to chronic-plus-binge alcohol while Adipor2 remained unchanged 
(Fig.2.4.11C). In A-Atg5 KO mice, the mRNA level of liver Adopor1 was slightly higher and 
Adipor2 was slightly lower than WT, and they were not changed after alcohol. This suggests that 
chronic-plus-binge alcohol treatment increased adipose adiponectin secretion possibly as an 
adaptive protection. The improved alcohol-induced liver injury in A-Atg5 KO mice was not due 




Figure 2.4.11 Serum adiponectin was increased in A-Atg5 KO mice and not further 
increased by chronic-plus-binge alcohol. 
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and serum and liver 
samples were collected 8h after binge. (A) Serum adiponectin level was measured by ELISA 
(n=6-8 mice per group). Data shown are mean±SEM, *p<0.05 (CTRL vs ETOH), #p<0.05 
(Cre- vs Cre+) by Student’s t test. (B) Serum was subjected to western blot in a non-heated, 
non-denatured condition. Ponceau S Red Staining was applied as the loading control. (C) Liver 




FGF21 is an anti-obesity, ant-diabetes hormone secreted by liver. It targets multiple organs 
including adipose tissue, and the role of FGF21 in ALD has been debatable (Zhao et al. 2015, Liu 
et al. 2016). We found that in WT mice, liver FGF21 had 72-fold increase in mRNA level and 2.5-
fold increase in protein level in response to alcohol (Fig.2.4.12A-C). In addition, there was 12-
fold increase in circulating FGF21 (Fig.2.4.11D). Interestingly, A-Atg5 KO mice had a higher 
basal level of liver FGF21 mRNA (5-fold) and circulating FGF21 level (2-fold) compared to WT 
mice. Liver FGF21 mRNA and protein levels were also increased after alcohol but by a smaller 
extent (20-fold and 1.8-fold, respectively) in A-Atg5 KO mice. Serum FGF21 level after alcohol 
was significantly lower in KO mice compared to WT. FGF21 binds to isoforms of FGF receptors 
facilitated by transmembrane protein β-Klotho/KLB. In liver we found there was no induction of 
mRNA level of Klb or Fgfr4 in A-Atg5 KO mice, indicating the KO mice may not have enhanced 
affinity to FGF21.This suggests that lower liver injury in A-Atg5 mice was not due to a higher 
FGF21 level after alcohol. However, the high basal levels of FGF21 in A-Atg5 KO mice could 
prime the mice and make them less sensitive when they are exposed to alcohol.   
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Figure 2.4.12 A-Atg5 KO mice had lower liver and serum FGF21 compared to WT after 
alcohol.  
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and serum and liver 
samples were collected 8h after binge. (A) Liver total protein was extracted and subjected to 
western blot. PC: FGF21 recombinant protein as positive control. β-actin was used as a loading 
control. (B) Densitometry of (A). (C) Liver was subjected to RNA extraction and qPCR (n=4-
5 mice per group). (D) Serum FGF-21 level was measured by ELISA (n=8-13 mice per group). 




2.4.7 Chronic-plus-binge Model Does Not Induce Adipose Inflammation in eWAT 
Chronic alcohol exposure for 4 weeks in rats induces inflammation and macrophage 
infiltration into adipose tissue (Kang et al. 2007). We next investigated whether chronic-plus-binge 
alcohol induced inflammation in adipose tissue in mice. We examined several pro-inflammatory 
markers including Tnfα, Il-6, F4/80 and Ccl2, and none of them increased by chronic-plus-binge 
alcohol. The expression levels of Tnfα, Il-6, F4/80 and Ccl2 were also not different between WT 
and A-Atg5 KO mice (Fig.2.4.13A). Increased crown structures, i.e. dead adipocyte(s) surrounded 
by macrophages in adipose tissue, is another pathological marker of adipose inflammation. We 
found the presence of crown structures in eWAT of WT and A-Atg5 KO mice in both CTRL and 
ETOH group (Fig.2.4.13B), but the total number was too little in any condition (less than 5 per 




Figure 2.4.13 Inflammation and cell death was not increased in eWAT after chronic-plus-
binge alcohol treatment in WT or Adipose-Atg5 deficient mice. 
WT and A-Atg5 KO mice were treated with chronic-plus-binge alcohol, and eWAT samples 
were collected 8h after binge. (A) eWAT was subjected to mRNA extraction and qPCR (n=4-
5 mice per group). Data shown are mean±SEM. (B) Representative images of crown structure 
(arrow head) in H&E staining (magnification=20x). 
Figure 2.4.13 
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2.4.8 A-Atg5 KO Mice Are Not Affected in Isoproterenol-induced Lipolysis Ex Vivo 
We continued to investigate the mechanisms of how A-Atg5 KO mice were protected from 
alcohol-induced adipose atrophy. We isolated eWAT and sWAT from WT and A-Atg5 KO mice 
and tested their response to isoproterenol, a beta adrenergic agonist that induces lipolysis. In WT 
mice, isoproterenol incubation increased free glycerol release by 1.5-fold in eWAT and by 2-fold 
in sWAT (Fig.2.4.14). The average free glycerol released in response to isoproterenol was slightly 
lower in A-Atg5 KO mice, but the induction fold was not significantly different from WT mice. 
This suggests that constitutional Atg5 deficiency in adipose tissue may not affect isoproterenol-





Figure 2.4.14 Adipose-Atg5 deficient mice were not affected in isoproterenol-induced 
lipolysis in fat ex vivo.  
eWAT and sWAT were collected from WT and A-Atg5 KO mice and subjected to ex vivo lipolysis 
assay. Pieces of adipose tissues were incubated with or without isoproterenol (10 μM), and free 
glycerol released in the medium was measured after one hour and normalized to tissue weight. (A) 
Absolute values were presented and (B) folds of induction compared to non-challenged group were 




2.5.1 Chronic-plus-binge Alcohol Induces Mild Adipose Atrophy but Not Inflammation or 
Fibrosis 
In our study, chronic-plus-binge alcohol treatment slightly decreased the mass of eWAT, 
sWAT, and rWAT while it significantly decreased BAT mass in Adipoqf/f Cre- mice. However, 
alcohol-induced reduction in adipose mass was more obvious and homogenous in 32-day chronic 
model and chronic-plus-binge model using C57BL/6J WT mice. Therefore, the mild adipose tissue 
atrophy we found in Cre- mice after alcohol is likely due to the mouse strain difference or different 
alcohol feeding models (see more detailed discussion below). Nevertheless, Cre- mice had more 
white adipocytes with smaller areas and brown adipocytes with decreased LD sizes in response to 
alcohol, therefore chronic-plus-binge alcohol may induce mild adipose atrophy in mice. In 
addition, we did not observe significant inflammation or cell death in adipose tissue after chronic-
plus-binge alcohol treatment.  
Several factors may contribute to the different response in adipose tissue to alcohol treatment. 
(1) Alcohol model: since length and route of alcohol administration affect the extent of liver injury, 
steatosis and survival rate (Brandon-Warner et al. 2012, Gao et al. 2017), it is possible that the 
extent of adipose atrophy, inflammation and fibrosis is also affected by different alcohol models. 
Decreased adipose mass and/or adipocyte size was observed in a 12-day chronic-plus-binge model 
in mice (Zhao et al. 2015), 4- to 24-week chronic feeding model in mice (Sun et al. 2012, Zhong 
et al. 2012, Crowell et al. 2016), and 4- to 12-week chronic feeding in rats (Kang and Nagy 2006, 
Zhang et al. 2015). So far there is no report of acute binge model inducing adipose atrophy, and in 
our hands the acute binge alone does not decrease adipose mass in WT mice (data not shown). 
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Increased adipose oxidative stress, inflammation and/or fibrosis was observed in a 25-day chronic 
feeding model in mice (Sebastian et al. 2011), and a 4-week chronic feeding model in rats (Kang 
et al. 2007, Tang et al. 2012). Interestingly in the 25-day feeding model, pro-inflammatory 
cytokines (TNF-α, IL-6, CCL2) and a fibrosis marker (CD11c) were transcriptionally upregulated 
at Day 25 but not at Day 18. Therefore, the extent of adipose atrophy and adipose injury (oxidative 
stress, inflammation) is likely to be time-dependent, and that might be why only mild adipose 
atrophy and no adipose injury was observed in our 10-day chronic-plus-binge model. In this 
chronic-plus-binge alcohol model, there is no severe lipodystrophy or increased pro-inflammatory 
cytokine secretion. However, a time-course experiment with longer exposure to alcohol and 
multiple binge may be very helpful. (2) Gene background: voluntary consumption of ethanol 
varies among different mouse strains (Belknap et al. 1993). Gao et al. reported that C57BL/6J mice 
were more sensitive to alcohol-induced mortality than C57BL6/N mice, they thus suggested that 
other background mice should be backcrossed into C57BL/6J background if genetically modified 
mice were used. In our lab, C57BL/6J WT mice seem to be more sensitive to alcohol-induced 
adipose atrophy than Adipoqf/f mice, though the Adipoqf/f mice were already backcrossed to 
C57BL/6J for more than 5 generations. It is not clear whether the different response is due to the 
different genetic background. We used littermates with similar gene background as WT control to 
minimize the influence from strains. (3) Gender: a study reported that female mice were more 
susceptible to chronic-plus-binge-induced liver injury, steatosis and adipose inflammation 
(Fulham and Mandrekar 2016). In our studies we used male mice for all in vitro assays. (4) 
Handling variation: though a standardized protocol has been established, it is still possible that the 
handing is different among researchers, resulting in various alcohol intake, binge-related 
mechanical injury, and stress in mice. Measurement of serum ethanol concentration will be helpful 
to make sure that comparable ethanol volume is conveyed to mice.  
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2.5.2 Constitutional Atg5 Deletion Using Adipoq-Cre Does Not Lead to Adipose Tissue 
Atrophy at Least at Early Ages 
A previous study reported that targeted Atg7 deletion in adipose tissue using aP2-Cre resulted 
in lower body weight since 4-week old and drastically reduced WAT mass at age of 18 to 20 weeks 
(Zhang et al. 2009). Atg5 whole body KO embryos and neonatal pups had decreased subcutaneous 
fat cells (Baerga et al. 2009). Abundant evidence suggests that autophagy inhibition either 
genetically or pharmacologically impairs adipogenesis in vitro. Based on these findings, we 
hypothesized that Atg5 KO in adipose tissue would result in impaired adipogenesis. However, we 
used 8- to 12-week male mice in our experiment, and found there was no significant difference in 
body weight or fat mass. We confirmed that there was partial Atg5 deletion and autophagy 
inhibition in WAT and BAT. There was still LC3-II protein in WAT and BAT, so the 
recombination was not 100% and the remaining Atg5 might be enough for normal adipogenesis. 
We found that there was no difference in food intake or body weight change between WT and A-
Atg5 KO mice, though physical activity and metabolic rate were not compared. 
Except the possible difference in strains and animal facilities, a possible explanation of this 
phenomenon is that we used a different promoter Adipoq-Cre here, which is more specific than 
aP2-Cre in adipose tissue. So far there are no other studies using Adipoq-Cre to delete autophagy 
genes in adipose tissue. A study used Ucp1-Cre to delete Atg12 in brown and beige adipocytes 
did not report reduced adipose mass or impaired adipogenesis (Altshuler-Keylin et al. 2016). These 
KO mice had less adiposity expansion after 8-week high fat diet (HFD) challenge. It is possible 
that inhibiting autophagy using Adipoq-Cre or Ucp1-Cre is not potent enough to impair 
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adipogenesis, while these mice may have different response upon obegenic diet, diabetic diet or 
other metabolic stress. It is intriguing whether A-Atg5 KO mice will be less resistant to HFD-
induced obesity or glucose challenge.  
A study by Ghosh et al. used aP2-Cre to PI3K catalytic subunit type 3 (Pik3c3), which is a 
subunit of PI3K that regulates intermembrane trafficking and autophagy activity. The authors 
found reduced adiposity in middle-age (12-month-old) and old-age (24-month-old) mice but not 
young (4-month-old) mice. They found increased ER stress marker CEB/P homologous protein 
(CHOP) and autophagy substrate p62 in adipose tissue, but change in LC3 protein was not 
described, so it is unclear how potent autophagy inhibition was in this KO model, and whether any 
autophagy-independent mechanisms contribute to the KO phenotype. However, it indicates that 
change in adipose tissue phenotype might be age-dependent. Insufficient autophagy occurs during 
aging and contributes to aging diseases (Rubinsztein et al. 2011). It is possible that aging adipose 
tissue is more sensitive to stress. Currently there are few studies on autophagy in aging adipose 
tissue. Ghosh et al. found decreased autophagy activity in old SVFs (from 18 to 20 month-old 
mice) compared to young SVFs (from 4 to 6 month-old mice) associated with increased ER stress 
and inflammation (Ghosh et al. 2016). It will be interesting to determine whether there will be 
altered adiposity and different response to metabolic stress in older A-Atg5 KO mice. 
Bif-1 is a positive mediator of autophagy by interacting with Beclin1 through UVRAG 
(Takahashi et al. 2007) and regulating Atg9 trafficking (Takahashi et al. 2011). Bif-1 KO mice had 
dampened autophagy activity in adipose tissue, but, unlike aP2-Cre Atg7 KO mice or Atg5 whole 
body KO mice, they developed obesity with aging and gained more weight after HFD (Liu et al. 
2016). These mice did not show impaired adipogenesis, and Bif-1 knockdown in 3T3-L1 cells did 
not inhibit preadipocyte differentiation. Therefore autophagy deficiency in adipose tissue may not 
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necessarily cause reduced atrophy, especially when other organs like liver and skeletal muscles 
were involved. To understand the role of autophagy in adipose tissue, using a tissue-specific KO 
model rather than whole body KO model will simplify the questions. 
Notably, studies using Adipoq-Cre to delete Raptor/mTOR or TSC1 exhibited reduced adipose 
tissue mass and body weight in mice at early ages (4 to 8 weeks) (Lee et al. 2016, Magdalon et al. 
2016, Shan et al. 2016). Since the mTOR signaling pathway determines many biological processes 
like protein synthesis, it is likely that mice with mTOR modulation in adipose tissue have impaired 
adipogenesis in both autophagy-dependent and autophagy-independent mechanisms. 
A limitation of using constitutional Adipoq-Cre in this study is that it may mix the impact of 
autophagy deficiency on adipogenesis at the early adipose development stage and the mature 
adipocytes. In ALD patients, usually adipogenesis is normal while the adipose tissue becomes 
unhealthy. To better determine the role of autophagy in mature adipocytes in ALD, an inducible 
KO model is preferable. One option is inducible Cre system which uses tamoxifen-dependent Cre 
recombinases (Feil et al. 2009). In this system, Cre sequence is fused with a tamoxifen-responsive 
estrogen receptor and retained in cytoplasm. When tamoxifen or 4-hydroxytamoxifen is 
administrated and binds to the estrogen receptor, CreER recombinase translocates into nucleus to 
work, and thus the timing of tissue-specific deletion is controlled. A CreERT2 system was 
introduced to Adipoq gene and achieve 97-99% recombination in WAT and ~15% recombination 
in BAT (Sassmann et al. 2010). However, tamoxifen induces acute fat loss and de novo lipogenesis 
in mice (Ye et al. 2015). Researchers are still modifying this system to minimize the toxicity of 
tamoxifen. Therefore to better determine the effects of genetic loss of autophagy in mature 




2.5.3 Constitutional Atg5 Deletion in Adipose Tissue Results in Increased Basal Levels of 
Adiponectin and FGF21 and Resistance to Alcohol-induced Liver Injury 
In 2013, Dr. Gao’s group established the chronic-plus-binge model containing 10-day alcohol 
feeding and an alcohol binge on the last day (Bertola et al. 2013). This model mimics human acute 
hepatitis and results in mild liver injury peaking at 9 h after binge and mild liver steatosis with no 
sign of fibrosis. Using this model, we found that the ALT and AST levels in A-Atg5 KO mice 
after chronic-plus-binge alcohol were much lower than WT in response to alcohol, therefore we 
concluded there was ameliorated alcohol-induced liver injury in A-Atg5 KO mice. 
Though previous studies in Dr. Gao’s group reported increased neutrophil infiltration and 
increased pro-inflammatory cytokines in liver and serum (Ki et al. 2010, Bertola et al. 2013, Xu 
et al. 2015, Li et al. 2017), we only found a slight increase in neutrophil infiltration, and no increase 
in liver mRNA levels of Tnf-α, Il-1β, or Il-6. We did observe increased mRNA levels of Ccl2 and 
carbonylated proteins in WT mice after chronic-plus-binge alcohol. The extent of liver injury and 
inflammation seems to be milder than previously reported (Bertola et al. 2013), and this might be 
the reason we did not see a further decrease in these parameters in A-Atg5 KO mice. As discussed 
earlier, the milder liver injury and inflammation might be due to the differences in mouse strain, 
sex, handling, and animal facilities. Moreover, younger mice (8- to 12-week-old) tend to have less 
injury then older mice (>12-month-old) in this model (Ramirez et al. 2017). 
To find the mediators responsible for A-Atg5-associated reduced liver injury after ethanol, we 
first checked adiponectin which is mainly secreted by adipocytes and can target liver. We found 
chronic-plus-binge alcohol increased serum total adiponectin level in WT mice, and A-Atg5 KO 
109 
mice had higher adiponectin at the basal level although it was not further increased after alcohol. 
The effect of alcohol on adiponectin level has been controversial in human studies (Sierksma et al. 
2004, Beulens et al. 2007) and in rodent models. Four-week alcohol feeding in rats or mice 
decreased circulating adiponectin in some studies (Chen et al. 2007, Song et al. 2008). However, 
a 4-week alcohol feeding in rats showed increased circulating adiponectin (Pravdova et al. 2009). 
A study using chronic-plus-binge model reported elevated serum adiponectin after alcohol 
(Fulham and Mandrekar 2016). So far there is no study on the impact of acute binge on adiponectin, 
thus it is unclear whether acute binge is exerting an impact on adiponectin that masks the effect of 
chronic feeding. In addition, a 6-week high-fat liquid ethanol diet in mice recorded circulating 
adiponectin, and found it started decreasing since the 3rd week (Xu et al. 2003). It is possible that 
adiponectin is induced by alcohol as an adaptive response, and the decrease in adiponectin happens 
under chronic exposure and in a later time point. An intragastric infusion of overfeeding together 
with alcohol over 4 weeks in mice resulted in synergistic steatohepatitis with increased serum 
adiponectin, suggesting that adiponectin might be affected by obesity in additional to alcohol (Xu 
et al. 2011). Moreover, we found the levels of HMW adiponectin were correlated with total 
adiponectin level, and MMW adiponectin did not differ much between treatments or genotypes. 
Though it was suggested different oligomers of adiponectin might have different physiological 
functions (Tsao et al. 2003), several studies on obesity and type-2 diabetes in humans found the 
HMW adiponectin concentration is consistent with total adiponectin level and has no superiority 
in prediction value (Blüher et al. 2007, Bluher et al. 2007, Almeda-Valdes et al. 2010, Zhu et al. 
2010). Adiponectin multimerization and HMW adiponectin in ALD is less studied. In our study, 
HMW level seemed to be associated well with total serum adiponectin, while MMW level did not 
change. Though the effect of alcohol on adiponectin is debatable, it is widely accepted that 
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adiponectin plays a protective role in ALD. Notably, A-Atg5 KO mice had increased total serum 
adiponectin and HMW adiponectin at basal levels although it was not increased after alcohol.  
Another potential mediator of the adipose-liver axis is FGF21. As a protective metabolic 
regulator, FGF21 is mainly synthesized in liver and can target multiple tissues including adipose 
tissue. Consistent with previous studies (Zhao et al. 2015, Liu et al. 2016), we found chronic-plus-
binge alcohol markedly increased liver and serum FGF21, which seems to be an adaptive response 
to liver injury. Interesting, in KO mice the basal levels of liver Fgf21 mRNA and serum FGF21 
were already increased significantly although the levels of FGF21 only increased mildly after 
exposure to alcohol compared with WT mice. In KO mice liver FGF21 protein was not paralleled 
with Fgf21mRNA, and it is possible that part of the FGF21 protein synthesized in liver was 
secreted to circulation. It should be noted that alcohol binge alone could induce serum FGF21 
elevation peaking at 6 h and gradually restoring to normal in human and mice (Desai et al. 2017). 
Therefore the effect of alcohol on serum FGF21 in the chronic-plus-binge alcohol is a mixture of 
chronic exposure and acute binge. Our results suggest that it is possible that the increased basal 
levels of adiponectin and FGF21 in A-Atg5 KO mice may prime these mice to be more resistant 
to alcohol-induced liver injury. Future studies are needed to further dissect how basal levels of 
adiponectin and FGF21 would affect the liver response to alcohol.  
 
2.5.4 Conclusions 
In conclusion, chronic-plus-binge alcohol leads to decreased adipocyte/LD size in mice, 
which is associated with inhibited Akt/mTOR signaling and enhanced autophagy in adipose tissue. 
This model is not potent enough to induce significant adipose inflammation or fibrosis. Atg5 
deletion using Adipoq-Cre in adipose tissue does not significantly affect adipose mass in mice 
111 
possibly due to remaining autophagy-related proteins. However, these KO mice are more resistant 
to chronic-plus-binge alcohol-induced adipose atrophy. Moroever, A-Atg5 KO mice are more 
resistant to chronic-plus-binge alcohol-induced liver injury but not steatosis. The constitutional 
autophagy deficiency in adipose tissue leads to increased basal adipokine and hormone levels 
including increased circulating adiponectin and FGF21, which may enable these mice more 









Figure 2.5.1 Scheme of the role of autophagy in chronic-plus-binge alcohol-induced 
adipose atrophy and liver injury. 
Potential role of autophagy in alcohol-induced adipose atrophy and liver injury: I. Upon 
chronic-plus-binge alcohol, adipocyte autophagy is activated in mTOR-dependent and mTOR-
independent pathways. Alcohol results in adipocyte atrophy and lipolysis, increased liver injury 
and steatosis, and increased serum adiponectin and FGF21 secretion as a protective response. 
II. In adipose-specific Atg5 KO mice, adipocyte autophagy is inhibited, and it subsequently 
increases beige adipocyte appearance and alleviates alcohol-induced adipose atrophy and liver 
injury, and decreases the secretion of protective mediators. WAT: white adipose tissue; BAT: 
brown adipose tissue; mTOR, mammalian target of rapamycin; Atg5, autophagy-related gene 
5; KO, knockout; FFA: free fatty acid; ALT: alanine aminotransferase; AST: aspartate 












CHAPTER 3. EFFECT OF AUTOPHAGY AND ALCOHOL ON ADIPOCYTE 




We previously investigated the role of adipose autophagy in alcohol-induced adipose atrophy 
and liver injury/steatosis in Chapter 2. To further understand the underlying mechanisms, we used 
3T3-L1 cell line, a type of preadipocyte that can be differentiated into adipocyte-like cells under 
adipogenic induction, as an in vitro model. We confirmed that 9-day incubation with adipogenic 
reagents led to a satisfying induction of adipocyte development by 3T3-L1 cells. We found during 
the adipogenesis of 3T3-L1 cells, there was increased mitochondrial protein but mitochondria 
showed diffuse staining pattern by tetramethylrhodamine methyl ester (TMRM) or MitoTracker, 
suggesting these mitochondria were undergoing abnormal remodeling. Electron microscopy 
studies also revealed significant accumulation of mitophagosome/mitochondrial spheroid like 
structures during the differentiation process. There was also increased autophagy degradation, and 
consecutive administration of lysosome inhibitor chloroquine (CQ) potently inhibited 
adipogenesis and changes in mitochondria. Constant administration of ethanol or acetaldehyde did 
not inhibit 3T3-L1 adipogenesis or changes of mitochondria morphology. In addition, short-term 
ethanol enhanced autophagy flux in differentiated 3T3-L1 adipocytes, and long-term ethanol 
exposure increased mitochondria protein levels. In summary, we found increased autophagic flux 
and dynamic mitochondrial remodeling during the in vitro differentiation of 3T3-L1 preadipocyte 




3T3-L1 cells are mouse fibroblasts that tend to accumulate TG in the form of LDs. There are 
multiple LDs with the nucleus remaining centrally located, resembling brown adipocytes and 
differentiating white adipocytes. Established in 1974 (Green and Kehinde 1974), this cell line has 
been widely used to understand adipocyte physiology under controlled conditions. The exact 
recipes and protocols for inducing adipogenesis in 3T3-L1 cells vary, but the following reagents 
are generally included: (1) insulin, an adipogenic hormone that regulates a series of transcription 
factors including cAMP-response element binding protein (CREB) (Reusch et al. 2000); (2) 
thiazolidinedione like troglitazone and rosiglitazone, an insulin-sensitizer and PPAR-γ agonist 
(Tafuri 1996); (3) IBMX, a nonselective phosphodiesterase inhibitor and adenosine receptor 
antagonist that raises cAMP level and activates PKA (Elks and Manganiello 1985); (4) 
dexamethasone, a glucocorticoid that regulates a series of nuclear factors.  
In our study, we applied 9-day incubation with a cocktail of the adipogenic reagents listed 
above to induce adipogenesis in 3T3-L1 cells. Using this in vitro model, we aimed to study the 
role of autophagy and mitochondrial changes in adipogenesis and the effect of alcohol on 
adipogenesis and adipocyte autophagy. 
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3.3 Materials and Methods 
3T3-L1 Cell Culture and Adipogenesis Induction. 3T3-L1 cells were maintained at 37°C in a 
humidified 5% CO2 atmosphere in DMEM (Hyclone) supplemented with 10% (v/v) FBS, 
penicillin and streptomycin (100 U/ml), and glutamine (100 μg/ml). To induce adipogenesis, 3T3-
L1 cells were seeded and propagated to confluence. Forty-eight hours after 100% confluence, 
which was designated as Day 0, cells were incubated in differentiation medium [10 μg/ml insulin, 
10μM troglitazone, 1 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX)] for 3 
days. At Day 3, cells were incubated in maintenance medium (5 μg/ml insulin, 10 μM 
troglitazone), and the maintenance medium was replaced every three days. 
 
Oil Red O Staining. Oil Red O stock solution and Millipore water (v/v=6:4) was mixed well and 
filtered through 125 mm filter paper to make working solution before use. For cultured cells, cells 
were washed once with PBS, fixed with 4% PFA at RT for 1h, and washed with 60% 2-propanol 
twice for 5 min. Then the cells were counterstained with hematoxylin for 1 min and washed with 
PBS. For quantification, the Oil Red O content was extracted from cells using 100% 2-propanol, 
and the OD value was measured by spectrometer at λ=492 nm. 2-propanol was used as blank 
control. 
 
Electron Microscopy. Cultured cells were seeded on Thermanox plastic coverslips (NUNC) in 
35 mm dish and fixed with 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.4) 
followed by 1% OsO4. After dehydration, thin sections were stained with uranyl acetate and lead 
citrate. Digital images were captured using a JEM 1016CX electron microscope. 
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Protein Extraction and Western Blot. Cultured cells were scraped and culture medium was 
collected, followed by centrifugation at 200g x 5min, RT. The cell pellets were washed with PBS 
and centrifuged again at 200 g x 5 min, RT. Then the cell pellets were homogenized in ice-cold 
RIPA buffer. After incubation on ice for 30 min, samples were centrifuged at 12,000 g x 15 min 
at 4℃. All protein lysates were supplemented with protease inhibitor cocktail. Supernatant was 
collected and protein concentration was determined by BCA assay. Samples were mixed with SDS 
loading buffer containing DTT and heated at 95 °C for 10 min unless otherwise indicated. Thirty 
micrograms of protein was separated by SDS polyacrylamide gel electrophoresis and transferred 
onto polyvinylidene difluoride membranes. Membranes were blocked in 5% milk in TBST at RT 
for 1 h, and then incubated with primary antibodies and secondary antibodies prepared in 5% milk 
in TBST. Signals were detected with SuperSignal West Pico Chemiluminescent Substrate and/or 
Immobilon Western HRP Substrate. Anti-LC3 antibody was generated as previously described 
(Ding et al. 2010). The following antibodies were used (Table 8). Densitometry was analyzed with 
Image J software. Band densities for the proteins of interest were normalized to β-actin unless 
otherwise indicated. 
Table 8 Summary of antibody information in Chapter III 
Antibody Company Catalog No. 
β-actin Sigma A5441 
GAPDH Cell Signaling 2118 
LAMP1 DSHB 1D4B 
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OXPHOS cocktail Abcam ab110413 
p62/SQSTM1 Santa Cruz sc-28359 
VDAC  Calbiochem AB10527 
 
Fluorescence Microscopy. Cells were seeded on a 12-well plate. TMRM, LipidTOX, and 
MitoTracker Green dyes (Thermo Fisher) were used following the manufacturer’s instructions, 
and images were taken in live cells. Fluorescence images were acquired under fluorescence 
microscope with MetaMorph software. For LipidTOX quantifications, cells with positive staining 
per field was counted for at least 4 fields in each group. 
 
Statistical Analysis. Experimental data will be subjected to Student’s t-test or one-way ANOVA 




3.4.1 Autophagic Flux is Increased during Preadipocyte Adipogenesis 
To determine autophagy status in adipogenesis of 3T3-L1 cells, we first established a 9-day 
3T3-L1 in vitro adipogenesis model. In this model, 3T3-L1 cells were incubated in induction 
medium for 3 days (Day 0-Day 3) and then in maintenance medium for 6 days (Day 3-Day 9). 
Fibroblast-like cells gradually became round and accumulated LDs (Fig.3.4.1). The proportion of 
adipocyte-like cells and the LD size increased over time, and by Day 9 over half of the cells were 
differentiated into adipocyte-like cells. Cells undergoing induction were compared with cells 
incubated with normal medium with no adipogenic reagents, and lysosome inhibitor CQ was 
added for 6 h before harvesting to assess autophagic flux in each time point. We found in cells 
undergoing adipogenesis, the levels of LC3-II markedly decreased in a time-dependent manner, 
and CQ treatment further increased the levels of LC3-II protein especially in early adipogenesis 
(Fig.3.4.2A, B). Surprisingly, autophagy adaptor p62 was not affected during induction or by CQ. 
LAMP1 is an outer lysosomal membrane protein, interestingly the LAMP1 band shifted up during 
adipogenesis. Cells treated with an ATPase inhibitor BAF, also increased the levels of LC3-II 
protein in differentiating cells (data not shown). In differentiating 3T3-L1 cells that were co-treated 
with CQ for 9 days, there were a large amount of electron-dense vacuoles containing undegraded 
cellular components (Fig.3.4.2C). Taken together, this suggests that there was increased 




Fig 3.4.1 Schematic of adipogenic induction in 3T3-L1 preadipocytes.  
Two days after 3T3-L1 cells were confluent, cells were incubated in induction medium for 3 
days, and then in maintenance medium for 6 days. Representative phase image and Oil red O 
staining of differentiating cells on Day 0, 3, 6 and 9 (counted since induction medium was 
added) were shown (magnification=10x). Experiments have been repeated at least 3 times 
independently. 
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Figure 3.4.2. Adipogenesis in 3T3-L1 cells involved enhanced autophagy degradation. 
3T3-L1 cells were induced for adipogenesis or maintained in regular medium for 9 days. (A) 
CQ (20 μM) was given 6 h before harvesting on Day 0, 3, 6 and 9, and cell lysate was subjected 
to western blot. β-actin was used as loading control. (B) Densitometry of (A) (n=4 individual 
experiments). (C) Representative EM images of non-treated (NT) cells on Day 0, differentiated 
(CTRL) cells on Day 9, and differentiated cells cotreated with CQ (20 μM) daily on Day 9. N: 





3.4.2 Dynamic Mitochondrial Remodeling During 3T3-L1 Preadipocyte Adipogenesis  
Mature white adipocytes are characterized by scarce cytoplasm and few mitochondria. It was 
proposed that autophagy is essential for the drastic remodeling of preadipocytes during 
differentiation at least by removing abundant mitochondria and cytoplasmic components (Baerga 
et al. 2009, Zhang et al. 2009). On the other hand, increased mitochondrial biogenesis was 
observed in 3T3-L1 preadipocyte adipogenesis (Wilson-Fritch et al. 2003). To determine the 
change of mitochondria content and function during adipogenesis, we examined levels of several 
mitochondrial proteins in differentiating 3T3-L1 cells. Cells undergoing induction had increased 
levels of oxidative phosphorylation (OXPHOS) complex I, II, III and V residing on inner 
mitochondria membrane (Fig.3.4.3A) over the time-course of 3T3-L1 differentiation. Moroever, 
there was increased voltage-dependent anion channel (VDAC) protein which localizes on the outer 
mitochondria membrane, which reached the highest levels in Day 9. CQ treatment for 6 h did not 
increase OXPHOS complexes or VDAC proteins. This suggests that there were increased 
mitochondria proteins in differentiating 3T3-L1 cells, and lysosomal degradation seems have little 
impact on the accumulated mitochondrial proteins. We found abundant elongated mitochondria 
with clear cristae structures in non-differentiated 3T3-L1 cells on Day 0 using EM. Surprisingly, 
much fewer numbers of mitochondria with clear cristae structures were found in 3T3-L1 cells that 
were cultured with the induction medium for 9 days (Fig.3.4.3B). Interestingly, we found 
increased number of round, electron-dense vesicles on Day 9. To find out whether there were more 
functioning mitochondria or only accumulation of dysfunctional morphology-remodeled 
mitochondria during adipogenesis, we performed TMRM and MitoTracker staining in 
differentiating cells. TMRM dye is cationic and stains mitochondria due to the mitochondrial 
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membrane potential and deceased mitochondrial membrane potential leads to loss of TMRM 
staining. MitoTracker is also a cationic fluorescence dye but it is usually sequestered in 
mitochondria due to its covalent binding with mitochondrial thiol-reactive chloromethyl moiety 
proteins. On Day 0, sharp elongated TMRM-positive mitochondria were observed in 
undifferentiated 3T3-L1 cells. Intriguingly, both the TMRM and MitoTracker signals were much 
stronger in adipocyte-like cells (with round shape and LD accumulation) than fibroblast-like cells, 
though the TMRM and MitoTracker signals were more diffused (Fig.3.4.3C). The diffuse 
mitochondria staining pattern by TMRM and MitoTracker in differentiated cells are somewhat 
associated with the markedly increased electro-densed structures identified by EM studies. 
Notably, CQ treatment during adipogenesis preserved the sharp elongated mitochondria structure 
just like cells incubated in regular medium, suggesting inhibition of lysosomal functions have little 
effects on mitochondrial remodeling during the 3T3-L1 differentiation. Taken together, there was 








Figure 3.4.3. Adipogenesis in 3T3-L1 cells involved increasing mitochondria proteins and 
remodeling. 
3T3-L1 cells were induced for adipogenesis for 9 days. (A) Cells undergoing induction or 
incubated with normal culture medium were treated with or without CQ (20 μM) for 6 h before 
harvested on Day 0, 3, 6 and 9, and cell lysate was subjected to western blot. β-actin was used 
as loading control. (B) Representative EM image of non-treated cells on Day 0 and 
differentiating cells on Day 9. N: nucleus. Scale bar: 500 nm. (C) Representative fluorescent 
images of non-treated cells on Day 0, differentiated cells on Day 9, and differentiating cells 
treated with CQ (20 μM) daily on Day 9 are shown. Live cells were subjected to TMRM and 
MitoTracker Green costaining. Scale bar: 20 μm. 
Figure 3.4.3 (Cont.) 
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3.4.3 Ethanol Does Not Inhibit 3T3-L1 Preadipocyte Adipogenesis  
To determine the effect of ethanol on 3T3-L1 adipogenesis, 3T3-L1 cells undergoing 
differentiation were treated with 100 mM of ethanol, 100 μM of acetaldehyde or 20 μM of CQ 
daily for 9 days. Adipogenic induction increased cells containing LDs at Day 9 as indicated by Oil 
red O staining (Fig.3.4.4A, C) and LipidTOX staining (Fig.3.4.4B, D), which was potently 
inhibited by constant CQ treatment. Ethanol or acetaldehyde cotreatment did not significantly 
decrease cells with positive Oil red O staining or LipidTOX staining compared with control. This 





Figure 3.4.4. Ethanol and acetaldehyde did not inhibit adipogenesis in 3T3-L1 cells.  
3T3-L1 cells were induced for adipogenesis and cotreated with ethanol (ETOH) (100 mM), 
acetaldehyde (MeCHO) (100 μM) or CQ (20 μM) daily for 9 days. (A) Representative images 
of Oil Red O staining of cells at Day 9 (magnification=20x). (B) Representative images of 
LipidTOX staining of cells at Day 9 (overlaid with Phase image, magnification=20x). (C) 
Quantification of Oil Red O staining at Day 6 and Day 9 (n=3-4 individual experiments). (D) 
Quantification of LipidTOX staining at Day 6 and Day 9 (n=3 individual experiments). Data 




3.4.4 Ethanol Increases Autophagic Flux in Differentiated 3T3-L1 Adipocytes  
The effect of ethanol on autophagy in 3T3-L1 adipocytes has not been studied. To test whether 
ethanol or acetaldehyde affects autophagy flux, 3T3-L1 cells undergoing 9-day differentiation 
were treated with ethanol or acetaldehyde for 24 h in the presence or absence of CQ. Ethanol alone 
increased LC3-II protein levels (1.5-fold), and CQ alone increased LC3-II protein levels to (1.7-
fold). Ethanol plus CQ further increased LC3-II protein (2.1-fold) compared with ethanol or CQ 
alone, while acetaldehyde plus CQ did not further increase levels of LC3-II protein compared with 
acetaldehyde or CQ alone (Fig.3.4.5). The levels of p62 protein were not significantly affected by 
any of the treatments. The effect of prolonged treatment of ethanol or acetaldehyde (daily for 3 
days) had similar effects on p62 and LC3 protein (data not shown). This suggests that ethanol 




Figure 3.4.5. Ethanol but not acetaldehyde induced LC3II turnover in differentiated 3T3-
L1 cells.  
3T3-L1 cells were induced for adipogenesis for 9 days. On Day 9, cells were treated with EtOH  
(100 mM) or MeCHO (100 μM) for 24 h and/or treated with CQ (20 μM) for 6 h before cell 
lysate was collected. Cells were subjected to protein extraction and western blot. (A) 
Representative western blot of p62 and LC3. β-actin was used as loading control. (B) 




3.4.5 Ethanol Increases Mitochondrial Proteins in Differentiating 3T3-L1 Cells 
The effect of alcohol on mitochondria content and function in 3T3-L1 during adipogenesis 
has not been well characterized. To determine the effect of alcohol on mitochondrial proteins, 
adipogenesis was induced in 3T3-L1 cells concomittant with ethanol (100 nM) acetaldehyde (200 
μM) or CQ (20 μM) treatment for 9 days. Consistently, the levels of OXPHOS complex I, II, III 
and V protein l all increased in cells undergoing adipogenesis compared with cells incubated with 
normal medium, and CQ treatment inhibited the increase of OXPHOS complexes (Fig.3.4.6A). 
Long-term ethanol treatment further increased the protein levels of all complexes, while 
acetaldehyde treatment did not. Similar to cells undergoing normal adipogenesis, EM studies 
showed that cells treated with ethanol or acetaldehyde had only a few mitochondria with clear 
cristae while they had an increased number of electron-dense vacuoles with undegraded cellular 
components (Fig.3.4.6B). To find out whether the morphology or the membrane potential of 
mitochondria were affected by alcohol, 3T3-L1 cells were stained with TMRM and MitoTracker 
Green. 3T3-L1 cells treated with ethanol or acetaldehyde had similar enhanced TMRM and 
MitoTracker signals in adipocyte-like cells compared with fibroblast-like cells (Fig.3.4.6C). In 
these groups, the TMRM signal was diffuse and not always colocalized with MitoTracker signal. 
These data suggest that ethanol but not its metabolite acetaldehyde further increases mitochondrial 
proteins but it seems that neither ethanol nor acetaldehyde affects the mitochondrial remodeling 







Figure 3.4.6. Ethanol but not acetaldehyde increased mitochondria protein in 3T3-L1 
cells. 
3T3-L1 cells were incubated with normal medium (NT) or undergoing adipogenesis with no 
other treatment (CTRL), EtOH (100mM), MeCHO (200μM), or CQ (20μM) cotreatment daily 
for 9 days. (A) Representative western blot of OXPHOS complexes. Cell lysate was collected 
on Day 9. GAPDH was used as loading control. (B) Representative EM images of 
differentiating cells with no other treatment, EtOH and MeCHO. N: nucleus. Scale bar: 1 μm. 
(C) Representative fluorescent images of differentiating cells with no other treatment, EtOH 
and MeCHO. Live cells were subjected to TMRM and MitoTracker Green costaining. Scale 
bar: 20 μm. 
Figure 3.4.6 (Cont.) 
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3.5 Discussion 
3.5.1 Increased Autophagic Flux and Mitochondrial Remodeling in Adipogenesis of 3T3-L1 
Preadipocytes 
In this study, we found that during adipogenesis, there was increased autophagic flux and 
levels of mitochondria OXPHOS and VDAC proteins. In EM studies, fewer elongated 
mitochondria with clear cristae structure were observed in mature adipocytes, while increased 
electron-dense vacuoles with undegraded cellular components appeared. While the differentiated 
adipocytes still have TMRM and MitoTracker staining, they showed striking diffuse pattern, 
suggesting possible altered mitochondrial structures and functions. It is possible that the electron-
dense vacuoles we saw might have derived from mitochondria and have contact with 
lysososomes/autolysosomes. This is supported by the observation that consecutive CQ treatment 
further increased the undegraded cellular components in these spheroids. Moreover, it is also 
possible that mitochondrial pH may be altered and become more acidic during the differentiation 
process of preadipocytes. This notion is supported by the observation that CQ-treated cells have 
the normal mitochondrial TMRM and MitoTracker staining, which is likely due to the 
neutralization of mitochondria pH by CQ. Future studies to co-stain cells with MitoTracker and 
LysoTracker in 3T3-L1 cells undergo differentiation will be helpful. We are also in the process of 
cloning a mitochondrial pH sensor which may also help us to test the mitochondrial pH hypothesis 
in the future. The lysosomal/autolysosomal removal of cellular components might be the key step 
or mitochondria remodeling. A proteomic analysis comprehensively studied mitochondria proteins 
in differentiating 3T3-L1 cells through day 0 to 18 (Newton et al. 2011). This study finds that 
during adipogenesis, 3T3-L1 adipocytes enter a “metabolic-overdrive” where TCA cycle and FA 
oxidation are enhanced. Interestingly, it was reported that pharmacological inhibition of autophagy 
136 
in early but not in later stages prevented 3T3-L1 adipogenesis by affecting mitochondria 
remodeling (Skop et al. 2014). Unfortunately, 3T3-L1 cells are not an ideal tool for genetic 
modulation to test the role of autophagy. Future studies to use COX8-GFP-mCherry system will 
help to better understand the dynamic process of mitochondria turnover. Costaining of 
mitochondria protein with LC3 or lysosome marker will be helpful to know whether the turnover 
is autophagosome/lysosome-dependent. 
3.5.2 Alcohol Does Not Impair Autophagy or Mitochondria Turnover in 3T3-L1 
Preadipocytes 
We found that short-term ethanol treatment induced autophagy, and long-term ethanol 
treatment enhanced mitochondria proteins in 3T3-L1 cells, both favoring 3T3-L1 adipogenesis. 
However, constant alcohol or acetaldehyde treatment did not affect LD accumulation or 
mitochondria change during adipogenesis Alcohol is mainly metabolized by ALDH and 
CYP2E1in liver and adipocytes. However alcohol metabolism in 3T3-L1 cells is not well 
understood. It was reported that exogenous CYP2E1 expression contributed to alcohol-induced 
oxidative stress and impaired adiponectin secretion in 3T3-L1 cells (Tang et al. 2012). Another 
study reported that ALDH2 activation promoted 3T3-L1 adipogenesis (Yu et al. 2016). It is not 
clear why in our hands, only alcohol but not acetaldehyde posed effects on autophagy and changes 
of mitochondria OXPHOS proteins. Since there are only few studies of ethanol in 3T3-L1 cells, 
the dose of ethanol and acetaldehyde we applied was based on the common dose used in other cell 
types like hepatocytes. Shorter time-course experiments (e.g. 6 h) and dose-response experiments 
are needed to fully characterized the effect of ethanol or acetaldehyde in 3T3-L1 cells. Enzyme 




In conclusion, 3T3-L1 preadipocyte adipogenesis involves enhanced autophagy and 
mitochondria remodeling. Autophagy is critical to the completion of mitochondria turnover. 
Ethanol does not impair autophagy or mitochondria remodeling, and does not affect adipogenesis 
in vitro. However, increased mitochondrial proteins and remodeling during 3T3-L1 adipogenesis 
are distinctly different from the adipogenesis in vivo or brown-to-white conversion in mouse 
adipose tissue. The above findings are summarized in Fig.3.5.1. Future studies to use primary 
adipocytes isolated from mice or human adipose tissues might be more suitable for study the effect 





Figure 3.5.1 Scheme of adipogenesis in 3T3-L1 preadipocytes.  
3T3-L1 preadipocytes change from fibroblast-like cells to adipocyte-like cells during 
adipogenesis, involving accumulated LDs, decreased typical mitochondria, and increased 
unidentified structures which might derived from mitochondria and/or lysosomes. I. The 
lysosome inhibitor CQ inhibits autophagy and blocks the remodeling of preadipocytes. II. 
Ethanol induces autophagy flux and does not impair the remodeling of preadipocytes. CQ: 














CHAPTER 4. OVERALL DISCUSSION AND FUTURE DIRECTIONS 
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4.1 Concluding Remarks 
In this study, we characterized the effect of chronic-plus-binge alcohol on mouse adipose-
liver axis. In addition to the known induction of liver injury and steatosis, chronic-plus-binge 
alcohol exposure led to white and brown adipocyte atrophy, increased adipose lipolysis and FFA 
released into blood, and increased secretion of protective crosstalk mediators, adiponectin and 
FGF21. Mechanistically, we found that chronic-plus-binge alcohol inactivated Akt/mTOR 
signaling and increased autophagic degradation in eWAT. Adipocyte inflammation and cell death 
were not induced in eWAT and thus did not contribute to liver injury or steatosis in this alcohol 
model, unlike reported in chronic alcohol feeding model. 
We investigated the role of adipocyte autophagy in adipose-liver axis in response to alcohol. 
Adipocyte autophagy inhibition by knocking out Atg5 did not significantly affect adipose mass. 
However, the KO mice were partially protected from alcohol-induced decrease in adipocyte size 
and elevation in liver ALT and AST, suggesting that adipocyte autophagy activation contributed 
to alcohol-induced adipose atrophy and liver injury. At the same time, the KO mice without 
alcohol exposure had increased basal levels of serum adiponectin and FGF21 compared to the WT 
mice, implicating that constitutional adipocyte autophagy inhibition led to altered adipokine and 
hepatokine secretion as an adaptive response. This supported the importance of autophagy in 
adipose function, and the significance of adipose-liver axis in ALD. 
We next used the 3T3-L1 cells to study autophagy and adipogenesis in vitro. We found 
increased autophagy degradation during the differentiation process, and this process could be 
completely blocked by the lysosome inhibitor CQ, suggesting that the normal lysosome function 
was indispensable for adipogenesis. Interestingly, while in differentiated cells the typical 
mitochondria drastically decreased, there was increased mitochondria protein along with 
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appearance of many electron-dense vesicles. In addition, these cells had diffused mitochondrial 
staining with membrane potential. This indicates that during adipogenesis the mitochondria were 
not simply removed, and it is possible that the electron-dense vesicles were derived from 
mitochondria. If so, the differentiated 3T3-L1 cells were more like brown adipocytes rather than 
white adipocytes in terms of mitochondrial content. Therefore, 3T3-L1 cells might not well 
represent the whole picture of adipose tissues in vivo, considering white adipose tissues have much 
more depots and are more important in lipid mobilization and adipokine secretion than brown 
adipose tissue.  
We also studied the effect of alcohol on 3T3-L1 cells. Ethanol or acetaldehyde of the dose we 
tested did not affect the induction rate of 3T3-L1 preadipocytes. This was consistent with the 
observation that ethanol or acetaldehyde did not impair autophagy flux or mitochondria 
remodeling, the two hallmark events in adipogenesis. In fact ethanol induced autophagy flux in 
differentiated 3T3-L1 cells, consistent with our observation in vivo. Besides, acetaldehyde did not 
affect autophagy flux or mitochondria protein during adipogenesis, suggesting that ethanol might 
pose effects on 3T3-L1 cells directly or via other metabolites. 
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4.2 Current Limitations and Solutions 
4.2.1 Assessing Autophagy in Adipose Tissues in In Vivo Alcohol Models 
In our study, we found decreased p62 and LC3-II proteins in eWAT after chronic-plus-binge 
alcohol. Since there was also inhibited Akt/mTOR signaling that suggests an overall catabolic 
status, we concluded chronic-plus-binge alcohol may increase autophagic flux in mouse adipose 
tissues. However, as mentioned in Chapter 1.3.1, autophagy is a highly dynamic process, and an 
autophagic flux assay using autophagy inhibitors is usually needed to accurately evaluate 
autophagy. Lysosome inhibitors (e.g. CQ, BAF, E64D+Pepstatin A) and lysosomal protease 
inhibitors (e.g. Leupeptin) that block autophagic degradation should be included in the chronic-
plus-binge alcohol model in the future to further assess autophagic flux. 
Another helpful model is to use the GFP-LC3 transgenic mice. In this model, autophagy 
marker LC3 is fused with GFP, so that autophagosomes characterized by GFP-positive puncta can 
be seen and quantified under fluorescent microscope in almost all the tissues except in the brain 
(Mizushima et al. 2004). Besides, during autophagic degradation free GFP proteins are cleaved 
from LC3-II, and free GFP fragments and GFP-LC3 proteins can be detected via western blot. 
Increased autophagic flux is usually associated with increased GFP-LC3 puncta, and increased 
free GFP fragments. Co-treatment using lysosome inhibitors could result in further accumulation 
of GFP-LC3 puncta. Using this model, our lab showed that protease inhibitor leupeptin further 
increased GFP-LC3 puncta, free GFP and GFP-LC3-II protein in mouse liver after chronic-plus-
binge alcohol, indicating increased autophagic flux in liver by alcohol (Chao et al. 2018). Future 
studies will be helpful to also assess the changes of GFP-LC3 puncta and levels in adipose tissues 
after alcohol.  
143 
Since mCherry or mRFP signal is more stable than GFP against quenching and degradation, 
several reporter models have been developed including mRFP-GFP-LC3 transgenic mice (Kimura 
et al. 2007), αMyHC-mCherry-GFP transgenic mice (Iwai-Kanai et al. 2008), mCherry-GFP-LC3 
transgenic mice (Terada et al. 2010), mice with mCherry-GFP-LC3 reporters delivered by AAV 
(Castillo et al. 2013), and GFP-LC3-RFP-LC3ΔG mice (Kaizuka et al. 2016). In these models, it 
is claimed that undegraded LC3 proteins have mCherry or RFP signal overlaid with GFP signal, 
and degraded LC3 proteins only have red signal. These models might be helpful to characterize 
autolysosome formation and degradation even without using lysosome inhibitors. It should be 
noted that mCherry or RFP signals still get degraded similar to GFP.  
There are some concerns of this type of models in combination with lysosome inhibitors. 
Firstly, a saturated dose of lysosome inhibitors is needed for accurate interpretation of autophagic 
flux assay. This is because free GFP fragments are affected by not only autophagy stimuli, but also 
lysosome activity and lysosome pH (Ni et al. 2011). Free GFP fragments in GFP-LC3 stable cell 
line can increase even in the presence of lysosome inhibitors if the dose is not saturated. Similarly, 
mRFP-LC3 puncta in mRFP-GFP-LC3 transfected cells can increase with unsaturated dose of 
lysosome inhibitors. Secondly, lysosome inhibitors have to target the interested organs and induce 
measurable changes. Autophagic flux assay using GFP-LC3 tg mice and lysosome inhibitors has 
been proved practical in liver (Ni et al. 2012, Lim et al. 2014, Chao et al. 2018), heart (Iwai-Kanai 
et al. 2008, Terada et al. 2010) and pancreas (Chu et al. 2015) in alcoholic and non-alcoholic 
disease models, but the application in other tissues like adipose tissue lacks reports. In our hands, 
strong free GFP fragments were detected even without any treatment, and co-treatment with CQ 
or Leupeptin hardly increased LC3-II, p62, free GFP, or GFP-LC3-II proteins in eWAT and iBAT 
of GFP-LC3 mice (data not shown). This suggests that in fat there might be highly active 
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autophagic degradation and GFP-LC3-II cleavage, and CQ or Leupeptin might not be potent 
enough to block the degradation or cleavage, though the same dose of CQ or Leupetin works well 
in liver and pancreas. An appropriate dose of CQ or a more potent lysosome inhibitor targeting 
adipose tissue are needed for completing the autophagic flux assay in the future. Thirdly, currently 
we only assessed autophagy status in fat 8 h after binge, while autophagy activity might fluctuate 
over time during the feeding and after the treatment. Observations at different time points may 
lead to different conclusions. 
 
4.2.2 Ex Vivo and Primary Cultured Cell Models for Studying on Alcohol and Adipose 
Tissue/Adipocytes  
To better control the experiment conditions of study on alcohol and adipose tissue/adipocyte 
physiology, several ex vivo and in vitro models have been developed. eWAT explants isolated 
from mice after chronic alcohol feeding were found to release more FFAs during 2 hours’ 
incubation in DMEM (Zhong et al. 2012). Mouse eWAT explants incubated with acetaldehyde for 
2 h also released more FFAs, and explants from adipose-lipin1 KO were resistant to acetaldehyde-
induced release of FFAs (Zhang et al. 2018). Besides, in rat eWAT explants incubated with 
acetaldehyde for 3 days, protein levels of lipogenic enzymes and regulators were decreased (Zhang 
et al. 2015). These observations prove that isolating eWAT explants from mice exposed to alcohol, 
and incubating eWAT explants with acetaldehyde, are practical ways to study the effect of alcohol 
on lipolysis and lipogenesis. In our study, we studied eWAT and sWAT ex vivo, and confirmed 
that the explants released more FFAs in response to isoproterenol-induced lipolysis, and the 
response was not significantly different in explants from A-Atg5 KO mice. It would be interesting 
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to see whether WAT explants from A-Atg5 KO mice are less sensitive to lipolysis after alcohol 
treatment in mice or acetaldehyde incubation with explants.  
Ex vivo assay reflects adipose tissue physiology as a whole tissue, while different types of 
cells in adipose tissue can be isolated and studied respectively. Using collagenase, cells are 
digested from fat pad, centrifuged, are separated into floating mature adipocytes and pelleted SVF. 
SVF contains heterogeneous cell populations including preadipocytes [also called adipocyte 
progenitors or adipose-derived stem cells (ASCs)], immune cells (like macrophages and T cells), 
endothelial cells, circulating blood cells, pericytes, and fibroblasts. Two cell types from adipose 
tissue have been studied in the alcohol context: (1) Mature adipocytes: Mature adipocytes from 
rats with or without alcohol feeding have been used for glucose transport, adiponectin secretion 
and adipocyte lipolysis assays (Sebastian et al. 2008). Adipocytes from chronic alcohol-fed rats 
had no difference in basal lipolysis, less sensitive to β-adrenergic receptor-induced lipolysis due 
to decreased accumulation of cAMP, and less sensitive to insulin-induced inhibition of lipolysis 
(Kang and Nagy 2006, Kang et al. 2007). Adipocytes but not SVF have increased CYP2E1 protein 
after chronic alcohol feeding, which may contribute to apoptosis and inflammation in adipose 
tissue (Sebastian et al. 2011). (2) Preadipocytes: Preadipocytes are multipotent and can 
differentiate into adipocyte-like cells when incubated with adipogenic reagents. Preadipocytes 
isolated from chronic alcohol-fed rats showed impaired expansion and adipogenesis (Huff et al. 
2011). In line with this, human adipocyte stromal cells had worse differentiation in the presence 
of ethanol (Crabb et al. 2011). It should be noted that the ratio and differentiation capacity of 
preadipocytes vary a lot due to fat depots, age, gene backgrounds, and environment (like diet) 
(Macotela et al. 2012). So far tno study has been reported to use preadipocytes from depots other 
than adipose tissue to study the impact of alcohol on adipocytes.  
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4.3 Future Directions 
Firstly, we would like to further investigate the role of autophagy in adipose atrophy and 
alcohol-induced liver injury. As discussed in Chapter 2.5, we performed the constitutional Atg5 
deletion in adipose tissue. Adaptation in response to adipose autophagy deficiency are likely to 
have happened over 2 to 3 months in mice, and may mask the different response to alcohol in A-
Atg5 KO mice. Acute autophagy knockdown via conditional KO models will help to focus on the 
consequences of adipose autophagy deficiency in ALD. As the effect of impaired differentiation 
in adipose tissue can be ruled out, a conditional KO model may be more relevant to ALD in humans. 
Secondly, we are interested in expanding the crosstalk study to gut-adipose-liver axis in ALD. 
In this study we used epididymal WAT as a representative visceral fat. Mesenteric WAT, another 
depot of visceral fat, is attached to intestines in a web-like form, and embeds blood vessels and 
lymphatic vessels stemming from gut to portal circulation or systematic circulation. The 
importance of gut-adipose-liver axis has been proposed in metabolic syndromes like obesity and 
type 2 diabetes (Konrad and Wueest 2014). In obesity, fat-enriched diet alters gut microbiota (i.e. 
the community of microorganisms in gut) composition, impairs gut barrier function, and increases 
pro-inflammatory cytokine production (Winer et al. 2016) (Portune et al. 2017) (Hamilton et al. 
2015). Increased bacterial particles and endotoxins may translocate into mesenteric WAT, 
stimulate adipocytes and resident immune cells to secrete pro-inflammatory cytokines, and 
predispose the body to obesity and insulin resistance (Cani et al. 2007). However, direct evidence 
is still lacking, and a few recent reports suggested that altered gut microbiota or gut barrier integrity 
was not important in diet-induced obesity and metabolic dysregulation in mice (Kless et al. 2015, 
Rabot et al. 2016). In ALD there is also altered dietary nutrient composition and microbiota, 
decreased gut permeability, and increased LPS translocation. It is intriguing whether there is 
147 
increased inflammation in mesenteric WAT, and if yes, whether it contributes to ALD like other 
adipose tissues. It should be noted that the findings related to gut microbiota in rodent models need 
to be translated to human cautiously, since microbiota composition varies a lot among species 
(Nguyen et al. 2015). 
Thirdly, it will be interesting and important to study the effect of alcohol on adipose-derived 
microRNA (miRNA) and the therapeutic value of adipose miRNA in ALD. miRNA is a naturally 
occurring, small non-coding RNA encoded by nuclear DNA. It silences RNA and post-
transcriptionally regulates gene expression. First described in 1993 (Lee et al. 1993), various 
miRNA populations have been found in different depots of adipose tissues (Kloting et al. 2009). 
miRNAs are associated with adipogenesis (Esau et al. 2004, Ortega et al. 2010), adipocyte fate 
determination (Sun et al. 2011, Mori et al. 2014), adipose inflammation (Ge et al. 2012, Ortega et 
al. 2015), lipid metabolism (Lin et al. 2014), obesity (Xie et al. 2009, Chartoumpekis et al. 2012, 
Ortega et al. 2013), and human immunodeficiency virus (HIV)-associated lipodystrophy (Mori et 
al. 2014, Squillace et al. 2014). miRNAs not only exert regulation in the cell per se, but also 
commute between different cells and distant tissues when they are excreted into exosomes, a type 
of cell-derived membrane vesicles (Valadi et al. 2007, Melo et al. 2014). Importantly, adipose 
tissue is a depot deriving circulating miRNAs which target multiple organs including liver. 
Recently Ying et al. found that miRNA-containing exosomes isolated from obese mice caused 
glucose intolerance and insulin resistance in lean mice, while exosomes from lean mice 
improved glucose intolerance and insulin resistance in obese recipients (Ying et al. 2017). 
Another recent study by Thomou et al. showed that mice with adipose-specific KO of miRNA-
processing enzyme Dicer (ADicer KO), circulating miRNAs especially exosomal miRNA were 
extensively reduced, and fat transplantation reconstituted circulating miRNAs (Thomou et al. 
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2017). They further found that human with HIV-associated lipodystrophy also presented 
decreased circulating exosomal RNAs. Intriguingly, ADicer KO mice had increased tissue 
Fgf21 mRNAs and circulating FGF21 levels, which could be reduced by BAT transplantation. 
As introduced in Chapter 1.4.4, FGF21 is a hormone mainly secreted in liver and may protect 
against liver injury and other metabolic dysfunctions. This study suggests that adipose-derived 
miRNAs are potential therapeutic targets of obesity and dysfunction in other tissues. Tissue 
miRNAs and circulating miRNAs are associated with alcohol-induced multi-organ injury 
including liver, pancreas, gut, brain, heart, and skeletal muscle (Natarajan et al. 2015). So far there 
is no report on the effect of alcohol on adipose miRNA or adipose-derived circulating miRNA. It 
remains to be studied whether any of these miRNAs would affect adipocyte autophagy, 
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